From fats to fluorescent fish: lipid modifications of sonic hedgehog ligand dictate cellular reception and signal response by Grover, Vandana Kaminie
FROM FATS TO FLUORESCENT FISH: LIPID MODIFICATIONS OF SONIC 
HEDGEHOG LIGAND DICTATE CELLULAR RECEPTION AND SIGNAL 
RESPONSE 
By 
VANDANA KAMINIE GROVER 
 
Dissertation 
Submitted to the Faculty of the  
Graduate School at Vanderbilt University 
in partial fulfillment of the requirements 
for the degree of 
DOCTOR OF PHILOSOPHY 
in  
Neuroscience 
December, 2011 
Nashville, Tennessee 
 
Approved: 
Lilianna Solnica-Krezel, Ph.D. 
Chin Chiang, Ph.D. 
Michael K. Cooper, M.D. 
Louis J. De Felice, Ph.D. 
Ethan Lee, M.D., Ph.D.
  
 
 
 
 
 
 
 
 
 
 
Copyright © 2011 by Vandana Kaminie Grover 
All Rights Reserved  
 	  
 iii	  
 
 
 
 
 
 
 
 
 
 
 
For my parents, Rani and Viren Grover, who instilled their love of science in me, 
and to my loving and supportive husband, Joshua Decker. 
 	  
 iv	  
ACKNOWLEDGMENTS 
 
 
“There's an old saying that victory has a hundred fathers and defeat is an 
orphan.” 
President John F. Kennedy, April 21, 1961 
 
President John F. Kennedy made that statement when he took 
responsibility for the Bay of Pigs fiasco. Though my graduate career is as far 
removed from a Cuban invasion as anything could be, his logic holds. My 
doctorate and this thesis would not have happened but for the warm, constant 
contributions of friends, family, mentors, and colleagues. I am privileged to thank 
them. 
I first must thank my advisor, Michael Cooper, for his tireless advice and 
mentorship. He combined a passion for science and good arguments with 
ceaseless support, patience, warmth, and good humor. Our discussions made 
me into a stronger, critically thinking scientist. 
Michael gave me an academic home, but Elaine Sanders-Bush and the 
Neuroscience Graduate Program made that home possible. Thank you for 
admitting me into this program and for providing a learning environment full of 
interesting classes, stimulating talks, and enjoyable extracurricular activities, all 
of which enabled me to grow and mature as a scholar. I also thank the entire 
Vanderbilt Brain Institute staff for their administrative assistance throughout the 
years.  
Thank you to my thesis committee, Lilianna Solnica-Krezel, Chin Chiang, 
Michael Cooper, Louis De Felice, and Ethan Lee, for their fruitful discussions and 
 	  
 v	  
useful ideas. I appreciate that they each freely gave their time, thoughts, and 
wisdom. They were instrumental in suggesting areas of investigation and honing 
my experimental course. Thank you specifically to Ethan for suggesting the 
HPLC experiments, to Chin for our detailed conversations about sonic hedgehog 
and for the joint Chiang-Cooper lab meetings, and to Lila for her expertise and 
assistance with zebrafish development. Lila was also a terrific committee chair: 
after every committee meeting, she provided me with wonderfully specific notes 
about each member’s suggestions: these were fundamental to my success. 
Finally, but certainly not least, thank you to Lou, who was not only a committee 
member, but also a kind mentor and a generous friend. As Neuroscience’s 
former Director of Graduate Studies, he immensely helped me during the 
beginning of my career. Lou is a fabulous teacher and provided me with a sense 
of confidence when I really needed it; without him, I would not be here today.  
For me, Juan Gerardo Valadez-Sánchez is heart of the Cooper Lab. 
Gerardo is a true friend. Gerardo helped me with experiments (I especially owe 
him for countless Maxi Preps), kept me well fed with his homemade Mexican 
specialties, and was always there with open ears and wise counsel. I am 
eternally grateful and cannot imagine my graduate career without his support. I 
also thank Tina Ho for introducing me to the world of molecular cloning and 
Nishka Narula for helping with ELISAs for a few weeks during the summer of 
2009.  
I thank Aaron Bowman for allowing us to use his HPLC. I could not have 
performed these experiments without Aaron’s troubleshooting skills and advice.  
 	  
 vi	  
In the summer of 2006, I was fortunate to be awarded a space at the 
Marine Biological Laboratory in Woods Hole, Massachusetts. This was an 
amazing experience: I learned new techniques, I met scientists who were 
passionate about their research, and I ate as much Cape Cod seafood as I could 
stomach. I am grateful to MBL for fostering a stimulating, inquisitive environment 
and for giving me a set of skills that I continue to use.  
I spent much of my graduate studies in the fish room with zebrafish. Adi 
Inbal is the one who taught me how to work with them and make transgenic lines. 
I owe my zebrafish skill to Adi. I also thank Alex Flynt and Chunyue Yin for 
imparting their expertise on zebrafish antibody staining and live imaging.  
Though Athena is the goddess of wisdom and skill, scientific knowledge 
does not spring full-born from anyone’s head: it is the product of intelligent 
dialogue and enlightened discussion. Thank you to Sunday Abiria, Catherine Au, 
Alexandre Benedetto, Iris Castro, Xi Huang, Wasif Khan, Wenyi Lo, Leta Moser, 
Sarah Rush, Anuraag Sarangi, Emily Schwartz Todd, and Niranjana 
Vijayakrishnan, for coffee, companionship, lunch breaks, and friendship through 
the years. All of them are wonderful people and gifted scientists; for their advice 
and thoughtful conversations, I am in their debt.  
I thank the Department of Neurology administrative staff, especially 
Rosemary Madill, Sandra Camp, and Brenda Farley for taking care of all the little 
things throughout the years and making my graduate career a more pleasant 
one.  
 	  
 vii	  
Robert Frost wrote, “Good fences make good neighbors.” Apparently, he 
never visited Vanderbilt’s Medical Research Building III. I thank the members of 
the Appel, Barnes, Bowman, Chiang, Ess, Gallagher, Hedera, and MacDonald 
labs for sharing reagents, for their collaborative working atmosphere, and for 
being great neighbors. 
Thank you to Gina Oka, Vijay Menon, Rita Dubey, Kruti Patel, and 
Ketevan Kulidzhanova for their years of friendship and support; I am honored to 
have these amazing people as some of my closest friends.  
Last, but certainly not least, thank you to my two wonderful and supportive 
parents, Rani and Viren Grover, who have provided me with all the opportunities 
in the world. Thank you finally to my husband, Joshua Decker, for his boundless 
love, unending kindness, and ceaseless assistance. 
 
 	  
 viii	  
PREFACE 
 
 
 
There once was a video game character, 
That created much joy and laughter. 
His inspiration was ironic, 
For he was a break from work, a tonic.  
And so a Hedgehog protein was named Sonic. 
 
 
Eponymous, 
With a name as funny as a hippopotamus, 
Sonic hedgehog has its character's traits: 
Twisted, powerful, and small, 
Adducts of palmitoyl, 
And a carboxy terminus of cholesterol, 
It affects zebrafish, mice, and humans all. 
 
 
Itself, inspiring Ancient Greeks to tell tales of cyclopia, 
Damning modern men with glioma and basal cell carcinoma. 
From genesis to death, 
Our two nostrils, with every breath. 
 
 
Neural tubes and Limbs, 
Regulated by Patched and Smoothened. 
Bilateral split, digits, not thumbs 
Governed by a morphogen. 
Its importance, mega. 
Not bad, for a protein named after Sega. 
 
 
 
Vandana K. Grover 
One sleepless night.  
circa ~ 2010 
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CHAPTER I 
 
 
INSIGHTS INTO HEDGEHOG PROCESSING, SIGNAL TRANSDUCTION, AND 
TISSUE PATTERNING 
 
 
1.1 Background 
 
Development of a multicellular organism from a single cell into discrete 
and organized structures requires the coordinated action of multiple factors. Cell 
specification is one of development’s quintessential questions. How a cell 
acquires its fate and what mechanisms underlie and facilitate the interactions and 
communications between cells is fundamental to our understanding of 
developmental biology. During gastrulation three germ layers, the endoderm, 
mesoderm, and ectoderm, originate from somatic cells. It is at this junction that 
pluripotent embryonic stem cells begin to undergo differentiation (Sasai and De 
Robertis 1997). Among the foremost players in this field is Hedgehog (Hh). Hh is 
a morphogen, a secreted signaling protein released from a localized source, and 
acts in a concentration dependent manner to pattern a field of tissue (Roelink et 
al. 1995; Teleman et al. 2001). Hh signals are varied and profound; in addition to 
its role as a morphogen, Hh controls a plethora of processes, including 
proliferation, cell survival, and axon guidance, in a multitude of systems from 
brain and spinal cord to limb and pancreatic development (Jessell 2000; Charron 
et al. 2003). Not only is Hh paramount during embryogenesis, but it plays a 
significant lifelong role in homeostasis and regeneration (Jiang and Hui 2008; 
Varjosalo and Taipale 2008). These processes are tightly regulated; 
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misregulation of the Hh signal transduction pathway results in numerous 
pathologies and malformations, including cancers such as meduloblastoma and 
basal cell carcinoma (Hahn et al. 1996; Johnson et al. 1996; Goodrich et al. 
1997; Oro et al. 1997; Taipale and Beachy 2001; Berman et al. 2003), and 
holoprosencephaly, a condition characterized by a spectrum of defects in midline 
facial and forebrain structures (Belloni et al. 1996; Chiang et al. 1996; Roessler 
et al. 1996; Cohen 2002). Gaining mechanistic insight into the role of Hh cellular 
secretion, reception and signaling is fundamental to our understanding of tissue 
patterning as it pertains to birth defects, tissue repair, and malignancies.  
 
1.2 Introducing Sonic hedgehog 
 
Historical background and expression profile 
 Since Nüsslein-Volhard and Wieschaus discovered the Hedgehog gene in 
the fruit fly, Drosophila melanogaster, its study has helped illuminate the mystery 
of cell-cell interactions. The Hh gene belongs to the class of segment polarity 
genes and was identified in a large-scale screen that examined impairments in 
the Drosophila melanogaster body plan. The normal Drosophila melanogaster 
larvae contains approximately eight abdominal segments. Anterior to the 
segments is a band of bristles, while the posterior side is smooth. The Hh 
mutation effects segment patterning, resulting in partial or complete segment 
deletion within the larvae and is named for its appearance, which includes an 
abnormal bristle pattern (Nusslein-Volhard and Wieschaus 1980). In the most 
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severe Hh-/- phenotype, the head segment fails to involute and all smooth cuticles 
from the posterior surface of each segment are lost, resulting in a lawn of bristles 
and an embryo that is approximately halved in size (Lee et al. 1992; Tabata et al. 
1992).  Hh homologs have been discovered in several organisms, both 
vertebrates and invertebrates, including Diadema antillarum or sea urchins 
(Walton et al. 2009) and Petromyzon marinus or lampreys (Sugahara et al. 
2011). This thesis, though, will focus on Hh studies in Mus musculus (mouse), 
Danio rerio (zebrafish), and Drosophila melanogaster (fruit fly). For simplicity, I 
will abbreviate Drosophila melanogaster as Drosophila.  
 Drosophila Hh was cloned in the early 1990s (Lee et al. 1992; Mohler and 
Vani 1992; Tabata et al. 1992; Tashiro et al. 1993) followed by the cloning of 
vertebrate Hh (Echelard et al. 1993; Krauss et al. 1993; Riddle et al. 1993). 
During vertebrate evolution, genome duplication and divergence of the Hh gene, 
resulted in three types of Hh subgroups in mammals and avian, Sonic hedgehog 
(Shh), Indian hedgehog (Ihh) and Desert hedgehog (Dhh). Shh expression is 
conserved across species in the notochord and floor plate, while Dhh and Ihh 
have varied expression patterns and can be found in the gonads and in bone 
growth plates respectively  (Bitgood et al. 1996; Vortkamp et al. 1996; Shimeld 
1999). In the embryonic mouse, the absence of Shh leads to several defects 
including but not limited to, mispatterning of the midline structures resulting in 
cyclopia and a proboscis (remnants of the nose and forebrain structures), 
shortening of the long bones, neural tube mispatterning, and loss of digits two 
through five (Chiang et al. 1996). Zebrafish, as a result of additional whole-
 	  
 4	  
genome duplication and other rearrangements (Jaillon et al. 2004), has two Shh 
homologs, tiggywinkle hedgehog (Twhh or Shhb) and Sonic hedgehog (Shh or 
Shha) (Ekker et al. 1995). Echidna hedgehog (Ehh), a homolog of Ihh is 
expressed also in the notochord  (Currie and Ingham 1996; Varjosalo and 
Taipale 2008).  
 Little is known about the initiation of Hh transcription. Some possible 
candidates that may be involved in regulating Shh expression include FoxA2, 
HNF3β, and Six3. FoxA2, a transcription factor, is an upstream positive and 
negative regulator of Shh expression. Chromatin immunoprecipitation studies in 
dopaminergic progenitors revealed that FoxA2 may act by binding directly to 
genomic regions of Gli2, a transducer of the Hh signal (Mavromatakis et al. 
2010). In zebrafish, Shh is co-expressed with axial (HNF3β), a transcription 
factor in the winged helix family, and improper regulation of axial leads to ectopic 
Shh expression. Additionally, in cell culture studies, HNF3β expression leads to 
activation of Shh gene promoter (Chang et al. 1997). Six3, a homeobox protein, 
binds Shh brain enhancer-2 (SBE2), an enhancer known to drive Shh expression 
in the forebrain. Furthermore, in the mouse diencephalon, Shh was determined 
to be a direct target of Six3 as reduced Six3 protein fails to induce Shh 
expression (Geng et al. 2008; Jeong et al. 2008). 
Multiple enhancer elements, unique to specific tissue types, also influence 
Shh transcription. Shh floor plate enhancer 1 (SFPE1) and SFPE2, direct Shh 
expression in the floor plate of the hindbrain and spinal cord, while SBE1, 
facilitates Shh expression in the ventral midbrain and parts of the diencephalon. 
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SBE2, SBE3, and SBE4, located farther upstream of the Shh transcription start 
site, lead to Shh expression in the ventral forebrain (Epstein et al. 1999; Jeong et 
al. 2006; Varjosalo and Taipale 2008). Loss-of-function studies demonstrate that 
another enhancer, mammals-fish conserved sequence 1 (MFCS1), is required for 
Shh expression in the limb bud zone of polarizing activity (ZPA) and mutations in 
MFCS1 in humans results in limb malformations (Sharpe et al. 1999; Lettice et al. 
2003; Sagai et al. 2004; Varjosalo and Taipale 2008). 
 
1.3 Hedgehog Structure, Processing and Lipidation 
 
Hedgehog structure 
 Full length Hh includes an amino terminal (N-terminal) signaling and a 
carboxy terminal (C-terminal) autoprocessing domain. A signal sequence peptide 
precedes the Hh amino terminal. The carboxy end consists of a Hint module that 
is commonly found in the intein region within self-splicing proteins. The Hh C-
terminus also contains a sterol-recognition region (SRR) that may be involved in 
the addition of the cholesterol moiety (see Hedgehog Biogenesis section for 
details) (Hall et al. 1997; Mann and Beachy 2004; Ingham et al. 2011).  
 Shh has homology with zinc hydrolases. The zinc ion associated with the 
Shh signaling domain is tetrahedrally coordinated with two histidines, an 
aspartate (D148) and usually a water molecule within a large cleft. The water 
molecule may form a hydrogen bond with glutamate acting as a base 
deprotonating water and making it available for nucleophilic attack of substrates. 
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In addition, mutational analysis of the Shh zinc coordinating residues highlighted 
their importance in Shh signaling and stability. These point mutations not only 
resulted in diminished Shh activity, but these mutants were also more susceptible 
to proteolysis. These zinc associated residues are conserved in vertebrates, but 
not Drosophila. (Hall et al. 1995; Hall et al. 1997; Day et al. 1999; Fuse et al. 
1999) (Reviewed in (Beachy et al. 2010)). 
 Several other studies have also looked at the structure of Shh and its 
interaction with additional proteins (McLellan et al. 2006; McLellan et al. 2008; 
Bosanac et al. 2009; Kavran et al. 2010), but one study in particular examines 
the interactions between Shh and the monoclonal mouse Shh 5E1 antibody. This 
antibody has been used several times and in different contexts throughout our 
studies, so it deserves a bit of attention. 5E1 is an anti-Shh monoclonal antibody 
and Hh pathway antagonist with neutralizing properties that has been extensively 
utilized in the study of Shh signaling in development and cancer. Mutation of 
specific surface residues disrupts binding to 5E1 and these same mutations also 
disrupt Shh and Patched (Ptc, a Shh pathway regulator that binds Hh) binding. 
Therefore, 5E1 most probably inhibits Hh signaling by competing with Ptc for the 
Shh zinc cleft binding site, thus acting as a negative pathway regulator (Fuse et 
al. 1999; Maun et al. 2010). Additional cell culture based studies also illustrate 
that pre-incubation of 5E1 with Shh inhibits binding to Ptc-expressing cells 
(Bosanac et al. 2009; Beachy et al. 2010).  
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Hedgehog biogenesis and lipid modifications 
Sonic hedgehog (Shh) undergoes substantial processing and post 
translational modifications prior to cellular release. There are putative Shh 
glycosylation sites in mice and four have been found in human Shh. Shh 
glycosylation is possible and has been shown in vitro studies that subject Shh 
proteins to pancreatic microsomal membranes, an artificial environment that 
promotes glycosylation (Bumcrot et al. 1995; Dorus et al. 2006).	   Unlike other 
similar proteins, glycosylation has not been conclusively demonstrated in the 
secreted signaling form of Shh protein (Nusse 2003).	  
Furthermore, upon entry into the secretory pathway, Shh precursor 
peptides undergo two nucleophilic displacement reactions in the endoplasmic 
reticulum (ER), resulting in a signaling domain and an autoprocessing domain. 
Following signal sequence elimination, cholesterol serves as a cofactor in an 
autocatalytic intramolecular cleavage reaction mediated by amino acid residues 
in the autoprocessing domain. Hedgehog cleavage occurs at an absolutely 
conserved Gly-Cys-Phe tripeptide site (Lee et al. 1994; Porter et al. 1995; Porter 
et al. 1996a; Hall et al. 1997; Chen et al. 2011). The first step of the internal 
cleavage reaction occurs between the Gly (G197 or G198 depending on the 
vertebrate species) and neighboring Cys that form the conserved tripeptide and 
involves rearrangement to replace the main chain peptide with a thioester from 
the Cys side chain. In the following step, the same carbonyl is attacked by a 
hydroxyl oxygen, this second nucleophilic attack displaces the sulfur atom and 
severs the link between the amino terminal (signaling domain) and carboxy end 
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of the full length Hh protein. Cholesterol remains covalently bound via an ester 
linkage to the newly formed carboxy terminus of the signaling domain at the Gly 
198 residue (Figure 1) (Lee et al. 1994; Porter et al. 1995; Porter et al. 1996a; 
Porter et al. 1996b). In vitro experiments demonstrate that other steroidal 
compounds such as desmosterol, 7-dehydrocholesterol, and lathosterol can be 
substituted for cholesterol and thus may be potential adducts in the autocatalytic 
cleavage reaction (Cooper et al. 1998). 	  
 A second lipophilic modification, catalyzed by the acyl transferase 
endoplasmic reticulum transmembrane protein Skinny hedgehog (Ski in 
Drosophila and Skn or Hhat (Hedgehog acyltransferase) in vertebrates), results 
in an amide linkage, via a thioester intermediate, of a fatty acid, typically 
palmitate, with the amino-terminal Cys (C24 or C25 depending on the vertebrate 
species) of the signaling domain. The modified Cys25 residue is part of 
pentapeptide, CGPGR that is conserved among species (Figure 1). Hhat, a 
member of the family of multi-pass transmembrane proteins MBOAT (membrane-
bound O-acyl-transferase), is specific to Shh palmitoylation and is, for example, 
unable to modify other proteins such as Wnt or PSD95. Palmitoylation most likely 
occurs in the lumen of the ER or Golgi (Pepinsky et al. 1998; Chamoun et al. 
2001; Lee and Treisman 2001; Buglino and Resh 2008). Furthermore, the 
efficiency of Shh palmitoylation is diminished in the absence of the cholesterol 
modification and may be due to reduced acylation or the lack of some processing 
sequences that are not available in the truncated or mutated Shh protein 
(Pepinsky et al. 1998; Mann and Beachy 2004). Shh palmitoylation, however, still  
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Figure 1. Shh biogenesis and lipid modifications. Upon entry 
into the secretory pathway, Shh undergoes an autocatalytic 
cleavage reaction resulting in a signaling domain modified by 
palmitate on the amino terminus and cholesterol on the newly 
formed carboxy terminus. This fully processed dual lipid modified 
form of Shh is the predominant signaling molecule in vivo. 
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occurs in the absence of Shh cholesterol modification. Radiolabeling experiments 
demonstrate that cholesterol modification of Shh is not required for palmitoylation 
and that in cell culture Shh lacking cholesterol (ShhN) still incorporates 
considerable amounts of radiolabeled palmitate (Chen et al. 2004; Buglino and 
Resh 2008). Additionally, in vitro, an artificially constructed N-myristoylated form 
of Shh also maintains signaling capability and cellular association (Taylor et al. 
2001).  Dual lipid modified or fully processed Shh is the predominant form of the 
signaling molecule in vivo. Lack of one or both lipids influences Shh signaling, 
trafficking, and potency (Pepinsky et al. 1998; Chamoun et al. 2001; Taylor et al. 
2001; Gallet et al. 2003; Chen et al. 2004; Mann and Beachy 2004; Li et al. 
2006).  
Until recently all known signaling functions of Hh were mediated by the 
Shh amino terminus or signaling domain. New studies, however, demonstrate a 
potential role for the full length unprocessed form of Shh protein as well. Hh 
responsive cells transfected with full length Shh, containing a point mutation 
(Shh-U) prohibiting the autocatalytic cleavage reaction, retain the ability to signal. 
Furthermore, Shh-U colocalizes with the Hh receptor Ptc and has the ability to 
induce cellular differentiation in chick embryos, albeit significantly diminished 
compared to the fully processed lipid modified Shh. A larger percentage of Hh-U 
was found in Drosophila embryos, suggesting that there may be a role for Hh-U 
in short range signaling or autocrine signaling (Hh is thought to act over short 
distances in the Drosophila eye) and not in tissues that require long range Shh 
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signaling for patterning (Tokhunts et al. 2010).  The relevance of Shh-U in vivo 
has yet to be determined.   
 
1.4 Hedgehog Signal Transduction 
 
Hedgehog receptors and its signaling cascade 
Several proteins coordinate Hh signal reception. Hh signaling occurs by 
direct binding of Hh ligand to Ptc (Marigo et al. 1996; Stone et al. 1996; Fuse et 
al. 1999). Ptc is a twelve transmembrane protein with sequence and structural 
similarity to related resistance-nodulation division (RND) family of bacterial 
proton driven pumps. These proton pumps employ a proton gradient to transport 
lipophilic molecules across the membrane (Paulsen et al. 1996; Ma et al. 2002; 
Piddock 2006). It is speculated that Ptc may be involved in translocating a small 
molecule that modulates Smoothened (Smo) activity (Taipale et al. 2002). Ptc 
also contains a sterol sensing domain (SSD), however, the Shh cholesterol 
adduct is not needed for Ptc binding, in fact, neither lipid moiety is required for 
Shh to bind Ptc (Williams et al. 1999).  There are two Ptc genes, Ptc1 and Ptc2 
(Motoyama et al. 1998). For the purpose of this thesis, Ptc refers to Ptc1 and is 
mentioned as either Ptc or Ptc1.    
In the absence of Shh ligand, Ptc is concentrated in primary cilia (Huangfu 
and Anderson 2005; Rohatgi et al. 2007) and acts catalytically to suppress the 
activity of Smo, a seven pass transmembrane domain (van den Heuvel and 
Ingham 1996; Taipale et al. 2002). Inactivation of Ptc by Shh binding inhibits its 
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catalytic activity (Stone et al. 1996; Taipale et al. 2002) and removes Ptc from the 
primary cilium, which thereby enables Smo to accumulate in ciliary membranes 
(Rohatgi et al. 2007; Milenkovic et al. 2009). This accumulation is followed by a 
secondary process converting Smo to an active state (Rohatgi and Scott 2008; 
Rohatgi et al. 2009) resulting in a transcriptional response through Gli proteins in 
vertebrates (Reviewed in (Jacob and Briscoe 2003)) (Figure 2). 
Due to its structure, Smo has long been thought to be a G-protein coupled 
receptor (GPCR). Recent studies from Drosophila and vertebrate cell culture 
suggest that Hh signaling may be occurring via the alpha subunit of the Gi family 
of G-proteins, however Smo can still signal independent of G-proteins (DeCamp 
et al. 2000; Riobo et al. 2006; Ogden et al. 2008). Thus, the requirement for G-
proteins may be context dependent. Furthermore, whether vertebrate Smo 
signaling requires G-proteins in vivo remains to be determined. 
Ptc, and additionally Hedgehog interacting protein (Hhip) in vertebrates, 
negatively regulate Hh signaling and availability by restricting its range of 
movement through tissue via a negative feed back loop that regulates Smo in the 
absence of Hh; both are also Shh transcriptional targets (Chen and Struhl 1996; 
Chuang and McMahon 1999; Goodrich et al. 1999; Jeong and McMahon 2005). 
In contrast, cell surface proteins cell-adhesion molecule-related down-regulated 
by oncogenes (CDO), Brother of CDO (BOC), and Growth Arrest Specific 1 
(Gas1) are positive regulators of the Hh pathway and directly bind Shh. Either 
CDO/BOC or Gas1, in addition to Ptc, are required for Shh mediated 
differentiation and proliferation. These accessory proteins may also form a  
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Figure 2.  Figure legend on following page.  
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Figure 2. Vertebrate Sonic hedgehog signaling pathway. Shown is the 
vertebrate Shh pathway from post translational modification and protein release, 
to cellular reception and generation of a transcriptional response modulated by a 
family of Gli transcriptional activators (Gli-A) and repressors (Gli-R). (A) Shh is 
secretion is mediated by Dispatched and is presumed to be secreted as a 
multimeric complex. (B) Shown are receiving cells and the various proteins that 
are involved in Shh trafficking. (C) Shown is the Shh signal transduction pathway, 
which can be mediated via the primary cilium. In the absence of Shh, Ptc is 
concentrated in the primary cilium and acts catalytically to suppress Smo. Upon 
Shh binding to Ptc, Ptc is inactivated and Smo accumulates in the cilium and is 
activated resulting in a transcriptional response mediated through Gli proteins. 
See text for details.   
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complex with Shh and Ptc to initiate signaling, but are not required for Shh to 
bind Ptc (Tenzen et al. 2006; Yao et al. 2006; Allen et al. 2007; Kavran et al. 
2010; Allen et al. 2011; Izzi et al. 2011). Shh binding to Cdo occurs 
independently of the Shh cholesterol adduct (McLellan et al. 2006; McLellan et 
al. 2008). 
 
Hedgehog accessory proteins and reception 
 Additionally, several accessory proteins are implicated in Shh signal 
regulation. Heparin sulfate proteoglycans (HSPG) are cell surface extracellular 
matrix molecules containing a core protein with covalently linked 
glycosaminoglycan chains (Perrimon and Bernfield 2000). Glypicans (GPC), a 
member of the HSPG protein family, have glycosylphosphatidyl inositol (GPI) 
anchors tethering them to the cell membrane, and are required for Hh reception 
and signaling (Lum et al. 2003; Yan and Lin 2009). Dally like protein (Dlp – 
Drosophila homolog of vertebrate HSPG) is essential for Hh movement and 
distribution (Han et al. 2004) and genetic evidence indicates that Dlp is required 
at or upstream of Ptc for Hh signal response in Drosophila embryos (Desbordes 
and Sanson 2003; Lum et al. 2003; Han et al. 2004). Specific regions on the 
surface of the Dlp core protein are required for normal responsiveness to Hh 
signaling, however the Dlp protein core does not directly interact with Hh (Kim et 
al. 2011).  
 In vertebrates, there are six GPC encoding genes that act as both positive 
and negative regulators of the Shh pathway. GPC4 shares the greatest 
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homology with Dlp (Bernfield et al. 1999). GPC4 and GPC6 are positive Hh 
pathway modulators and rescue Dlp function and Hh response in Drosophila 
cultured cells, whereas GPC 1, 2, 3, and 5 show no effect (Williams et al. 2010). 
In contrast, GPC3 inhibits Shh signaling by competing with Ptc for Shh and 
promotes endocytosis and degradation (Capurro et al. 2008; Jiang and Hui 
2008). To initiate proliferation, however, Shh interacts with HSPGs via the 
Cardin-Weintraub motif, which binds heparin. This region though, is not required 
for Shh to bind Ptc (Rubin et al. 2002; Chan et al. 2009). In addition to signaling, 
HSPGs also modulate Hh distribution. Shh can be found concentrated in clusters 
around HSPGs. In a mutated form of HhN that negatively affects clustering, Hh 
was unable to interact with HSPGs and failed to signal over a long distance, but 
retained autocrine signaling activity (Vyas et al. 2008). HSPGs may also be 
involved in Hh transport to target cells (The et al. 1999) or multimerization (Ohlig 
et al. 2011). Thus, glypicans are involved in trafficking Shh while also positively 
and negatively modulating signaling.  
 
Sonic hedgehog as a morphogen in graded signaling 
Cellular exposure to developmental factors are a heterogeneous function 
of signal type, signal duration, and cellular location. The Hedgehog family of 
signaling proteins are morphogens secreted from localized sources such as the 
zone of polarizing activity (ZPA) in the limb bud, and the notochord and floor 
plate in the developing spinal cord. Morphogens directly elicit concentration-
dependent responses in neighboring cells to influence the patterning of 
embryonic structures, such as the ventral neural tube (VNT) and limb bud 
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thereby impacting cellular specialization (Teleman et al. 2001; Harfe 2011). 
Changing as a function of concentration, Hh signaling influences cells in close 
proximity to the signal source (short range signaling) as well as those a greater 
distance away (long range signaling) (Jessell 2000; Teleman et al. 2001).  
The concept of a morphogen gradient is best characterized in the VNT 
and was brought on by studies in the developing spinal cord of chick embryos. 
Neural plate explants were subjected to varying concentrations of Shh protein. 
Unique cell fates were induced depending on the concentration of Hh. The dose 
requirement needed correlates well with the position that domain would occupy in 
the dorsal to ventral position in the VNT. The threshold concentration of Shh 
required to induce motor neurons, for example, is higher than that required to 
define more dorsally located interneurons (Roelink et al. 1994; Roelink et al. 
1995; Chiang et al. 1996; Ericson et al. 1996; Ericson et al. 1997; Briscoe et al. 
2001) (Figure 3).	  The activity of Shh ligand is not only based on concentration, 
but also on duration of signal (Harfe et al. 2004; Dessaud et al. 2007). In chick 
neural cell experiments, signal duration is proportional to Shh concentration. 
Over time cells become desensitized to Shh resulting in up-regulation of Ptc; Gli 
expression decreases as Ptc is upregulated. This leads to a conversion of Shh 
concentration to a specific period of Gli activity and more ventral target genes are 
expressed. Neural cells convert different concentrations of Shh into specific 
periods of signaling (Jeong and McMahon 2005; Stamataki et al. 2005; Dessaud 
et al. 2007).          
 Varying combinations of homeodomain transcription factors are induced in 
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Figure 3.	   Shh regulated gene expression profiles within progenitor cell 
domains in the ventral spinal cord. (A) Shown are the expression profiles 
of transcription factors regulated by graded Shh signaling. (B) Along the 
dorsal-ventral axis of the developing neural tube are six domains of progenitor 
cells (floor plate, p3, pMN, p2, p1, and p0) which generate different ventral 
motor and interneurons. This spatial organization is formed by a gradient of 
Shh protein (blue dots) secreted from the notochord and floor plate. Not 
shown is the effect of time and duration of Shh protein signal in shaping the 
morphogen gradient. After neural tube closure, postmitotic cells migrate to 
various positions within the spinal cord. 
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response to graded signaling within progenitor cells to yield at least five distinct 
neuronal subtypes. Homeodomain proteins are divided into two classes on the 
basis of their patterns of expression and regulation by Shh. Shh represses class I 
proteins (e.g. PAX6 and PAX7), thus they are expressed in the dorsal half of the 
neural tube. Conversely, Shh signaling is required for class II protein expression 
(e.g. Nkx2.2) which is focused in the ventral half of the neural tube (Figure 3). 
The interaction between these two classes of proteins, regulated by Shh among 
other signaling molecules, maintains and defines the boundaries of progenitor 
domains in the neural tube (Briscoe et al. 2000; Ribes and Briscoe 2009).  
The distribution and spread of Shh ligand in target tissue is also regulated 
by extracellular transmembrane proteins such as CDO, BOC, and Gas1 that 
were described previously as positive regulators of the Shh pathway. The floor 
plate is reduced in Cdo-/- mice and in Gas1-/-; CDO-/- mouse embryos, the floor 
plate in addition to ventral interneuron 3 and motor neurons are absent. Thus 
these factors may be involved in enhancing Shh signaling in the VNT (Tenzen et 
al. 2006; Allen et al. 2007). Furthermore, Ptc negatively regulates Shh signaling 
and is also transcriptionally upregulated by Shh (Chen and Struhl 1996; Chuang 
and McMahon 1999; Goodrich et al. 1999). When chick embryos were 
electroporated with a mutant form of Ptc no longer able to bind Shh, there was a 
reduction in Shh signaling in the electroporated area and a ventral to dorsal shift 
in neuronal fate (Briscoe et al. 2001). Additionally, the family of Gli activator and 
repressor proteins form their own gradients within the neural tube that also 
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control cellular differentiation (Reviewed in (Ribes and Briscoe 2009)). Thus, 
there are many regulatory factors that influence differentiation in the VNT.  	  
1.5 Hedgehog Trafficking, Secretion, and Reception 
 
Secretion and release of Hedgehog protein 
Shh lipid adducts modulate cellular secretion and reception. Lipid modified 
Hh is targeted to lipid raft microdomains within the cell, associating the ligand 
with cell membranes (Rietveld et al. 1999), such that the secreted signaling 
domain is tightly associated with Hh generating cells. Specialized machinery, 
namely Dispatched1 (Disp1), has evolved to secrete and release Shh for 
distribution. Disp1 is structurally similar to Ptc, has a SSD, and is also a member 
of the RND family of transport proteins. Disp1 mediates secretion of cholesterol 
modified Shh and also plays a role in long range signaling. In addition, loss of 
Disp1 leads to Hh accumulation in producing cells; HhN on the other hand does 
not require Disp1 for cellular release (Burke et al. 1999; Caspary et al. 2002; 
Kawakami et al. 2002; Ma et al. 2002). Though, Disp1 is not required to generate 
a Shh response, it thought to be involved in Shh spread and distribution as well 
as long range signaling (Burke et al. 1999; Ma et al. 2002; Saha and Schaffer 
2006; Etheridge et al. 2010). Additionally, in other proteins with SSDs, this sterol 
sensing domain regulates the stability of these proteins response to cholesterol. 
It is still unclear whether Disp responds to sterol levels or what the specific roles 
of the Shh lipid adducts are in cellular release (Chang et al. 2006; Eaton 2008).  
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Shh multimeric complexes  
Hh signal is released as a multivalent particle or multimer (Zeng et al. 
2001), and in Drosophila these multimers are associated with lipoproteins 
(Panakova et al. 2005). The role or existence of lipoprotein in vertebrate Shh is, 
however, unknown (Eaton 2008). Multimerization requires both the palmitoyl and 
cholesterol lipid adducts and is thought to be the biologically active form of Shh 
(Zeng et al. 2001; Chen et al. 2004; Goetz et al. 2006). Smaller sized multimers, 
however, have also been described and need only one lipid adduct to form (Feng 
et al. 2004). Shh multimers are also thought to be more potent than Shh 
monomers and may be involved in long range signaling (Zeng et al. 2001; Chen 
et al. 2004). The multimeric form of Shh, however, has not been observed via 
rigorous structural analysis (Kavran et al. 2010).  
 
Hedgehog cholesteryl and palmitoyl modifications 	    Lipid modifications influence the localized release, propagation, and 
reception of Hh signal over several cell diameters. The mechanisms by which 
these lipid modifications influence trafficking have been the subject of many, 
often conflicting, studies. Neither cholesterol nor palmitate is required for Hh 
binding to Ptc (Williams et al. 1999) or to initiate signaling, but both are needed 
for proper secretion and spatial distribution of Shh (Chamoun et al. 2001; Lewis 
et al. 2001; Chen et al. 2004; Li et al. 2006).  
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The cholesterol adduct appears to function as a lipid anchor. In cultured 
cells, cholesterol modified Shh is membrane associated, while those lacking the 
cholesteryl moiety (ShhN) are more freely secreted into the culture medium 
(Porter et al. 1995). Both Drosophila and murine Hh partition into detergent 
insoluble glycolipid complexes (called DIGs, lipid microdomains, or lipid rafts) 
(Simons and Vaz 2004), so the cholesterol adduct appears to influence the 
subcellular localization of Hh proteins and may tether Hh to the site of production 
while restricting its spread across the field of neighboring cells. Similarly, 
localized expression of Hh lacking only cholesterol broadens tissue distribution 
and range of signaling (Porter et al. 1996a; Burke et al. 1999; Li et al. 2006; 
Huang et al. 2007) as Shh is secreted farther and results in ectopic pathway 
activation (Li et al. 2006; Guerrero and Chiang 2007). In fact the cholesterol 
moiety enhances local concentration while anchoring Hh to the cell membrane 
(Saha and Schaffer 2006). Interpretation of these data have been complicated by 
conflicting results stating that cholesterol is required for long range signaling 
(Lewis et al. 2001). This disparity may be due to the different Hh expression 
levels of the mutant forms of ShhN used in the studies (Varjosalo and Taipale 
2008).  
The palmitoyl adduct also imparts an additive membrane anchoring effect 
(Feng et al. 2004) and the hydrophobic nature of the amino-terminal lipid 
enhances Shh potency (Taylor et al. 2001). Palmitoylation also influences 
proteolytic removal of Shh amino terminal residues allowing multimeric Shh to 
bind Ptc (Ohlig et al. 2011). In cell-based assays removal of either of the lipid 
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adducts abolishes (Chen et al. 2004) or greatly reduces signaling (Williams et al. 
1999; Taylor et al. 2001). In Drosophila, Hh protein that lacks a palmitoyl adduct 
(ShhC25S) fails to signal (Chamoun et al. 2001) and ventral neural tube 
patterning is disrupted in ShhC25S and Skinny Hedgehog (Skn)-/- mice (Chen et 
al. 2004). Localized expression of Hh lacking only the palmitoyl moiety decreases 
long range signaling (Chamoun et al. 2001; Chen et al. 2004) while the opposite 
is true in the absence of the cholesterol adduct (Porter et al. 1996a; Burke et al. 
1999; Li et al. 2006; Huang et al. 2007).  
As discussed, Hh protein is post-translationally modified by two lipids, 
cholesterol and palmitate. In fact, it is the only known protein to be covalently 
modified by cholesterol (Mann and Beachy 2004). Curiously, Hh is involved in 
long range signaling, and it is not spatially restricted by anchoring cell 
membranes (Porter et al. 1996a; Porter et al. 1996b; Chamoun et al. 2001). A 
better understanding of this dichotomy between Hh biochemistry and morphogen 
activity requires an in depth look at the roles of both lipid adducts, their biological 
relevance, and their influences on Hh trafficking and signaling.  
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CHAPTER II 
 
 
LIPID MODIFICATIONS OF SONIC HEDGEHOG LIGAND DICTATE 
CELLULAR RECEPTION AND SIGNAL RESPONSE 
 
 
2.1 Introduction 
 
The Hedgehog (Hh) family of signaling proteins are secreted from 
localized sources and elicit concentration-dependent cellular responses to 
specify tissue pattern during development and homeostasis (Jessell 2000; Jiang 
and Hui 2008). Proper Hh ligand distribution and reception are essential for the 
full repertoire of graded cellular responses; human birth defects and 
malignancies are attributed to the misregulation of Hh signaling (Hahn et al. 
1996; Johnson et al. 1996; Muenke and Beachy 2000; Cohen 2002). A unique 
biochemical property of the secreted Hh signaling domain is covalent 
modification by cholesterol and palmitate. Following signal sequence cleavage, 
cholesterol serves as a cofactor in an autocatalytic intramolecular cleavage 
reaction and remains covalently bound to the carboxy-terminal Gly residue of the 
newly formed signaling domain (Lee et al. 1994; Porter et al. 1995; Porter et al. 
1996a; Porter et al. 1996b; Hall et al. 1997). The second hydrophobic 
modification is catalyzed by the acyl-transferase Skinny hedgehog, which results 
in the amide linkage of palmitate to the amino-terminal Cys residue of the 
signaling domain (Pepinsky et al. 1998; Chamoun et al. 2001; Lee et al. 2001). 
Hydrophobic modification confers membrane affinity such that the 
secreted signaling domain is tightly associated with Hh-generating cells (Lee et 
 	  
 25	  
al. 1994; Porter et al. 1996a; Feng et al. 2004). The cellular release of cholesterol 
modified Hh ligand is regulated by the transmembrane protein Dispatched (Burke 
et al. 1999; Ma et al. 2002; Saha and Schaffer 2006). Thus, one biological 
function of the lipid moieties is to restrict the spatial deployment of Hh 
morphogens. Hh is secreted as multivalent particles (Zeng et al. 2001; Panakova 
et al. 2005) whose formation requires the presence of both lipid additions to the 
signaling domain (Zeng et al. 2001; Chen et al. 2004; Goetz et al. 2006). Thus, it 
has been proposed that both lipid moieties are required for long range signaling 
(Lewis et al. 2001; Zeng et al. 2001; Chen et al. 2004; Goetz et al. 2006). 
Conspicuously, however, lipid modification is not a requisite for high-affinity 
binding of Hh ligand to Patched1 (Ptc1) and other receptor complex proteins 
(Fuse et al. 1999; Williams et al. 1999; Taylor et al. 2001; McLellan et al. 2008; 
Zheng et al. 2010). 
A clear understanding of how lipid modification influences signal reception 
has been hampered by conflicting results. Notably, the earliest in vitro signaling 
assays utilized purified Sonic hedgehog (Shh) lacking both cholesterol and 
palmitate adducts (Hall et al. 1995) to elicit the full repertoire of graded signaling 
responses in explanted chick neural plate ectoderm (Roelink et al. 1995; Ericson 
et al. 1997). Conversely, in cell-based assays, removal of either of the lipid 
adducts abolished (Chen et al. 2004) or greatly diminished signaling (Williams et 
al. 1999; Taylor et al. 2001). In Drosophila and mouse embryos, localized 
expression of Hh lacking only the palmitoyl moiety decreased long range 
signaling (Chamoun et al. 2001; Chen et al. 2004) whereas the localized 
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expression of Hh lacking only cholesterol broadened tissue distribution and range 
of signaling (Porter et al. 1996a; Burke et al. 1999; Li et al. 2006; Huang et al. 
2007). 
A major constraint of in vivo model systems to elucidate the influences of 
the lipid adducts on Hh signaling is the inability to distinguish an effect on tissue 
distribution, and thus local concentration, from an effect on signal potency. 
Another limitation centers on tissue-specific differences in sensitivity to Hh 
signaling (Huang et al. 2007). With regard to cell-based assays, we report a 
profound loss of signal reception sensitivity in cloned and high-passage cell lines 
used in prior studies (Cooper et al. 2003; Chen et al. 2004; Goetz et al. 2006). To 
circumvent some of these limitations, we used early-passage NIH3T3 fibroblasts 
and assays with enhanced sensitivity to integrate quantitative measurements of 
Shh concentration, cellular localization, and potency to evaluate the influences of 
lipid modification on Shh signaling. We demonstrate that the lipid adducts serve 
critical functions in cellular reception, governance of cell concentration, and 
signal potency of Shh ligand. 
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2.2 Materials and Methods 
 
Preparation of complementary DNA (cDNA) constructs  
The pRK5-Shh construct was used to express full length mouse Shh. The 
pRK5-ShhN construct carries an open reading frame truncated after Gly-198 and 
was used to express Shh lacking cholesterol (Roelink et al. 1995). To eliminate 
palmitoylation, PCR site-specific mutagenesis by overlap extension (Sambrook 
and Russell 2001) was performed with pRK5-Shh as cDNA template (Platinum® 
Blue PCR SuperMix, Invitrogen) with the following primers: 1) 5’ -CCC GGG CTG 
GCC GCT GGG CCC GGC AG- 3’ (mutates Cys-25 to Ala-25; ShhC25A), 2) 5’-
CCC GGG CTG GCC AGT GGG CCC GGC AG- 3’ (mutates Cys-25 to Ser-25; 
ShhC25S) and 3) 5’ -TGT GCC CCG GGC TGG CCG GGT TTG GAA AGA GGC 
GGC ACC C- 3’ (deletes Cys-25 through Arg-29; Shh(n-5)). To eliminate both 
cholesterol and palmitate modification, the primers listed above were used in 
conjunction with 5’-GCG GCC AAA TCC GGC GGC TAG GTC GAC TGC-3’ to 
create a stop codon after Gly-198. All constructs were sequenced for verification 
(Genepass Inc.).  
 
Cell culture and transfection   
 NIH3T3 mouse embryonic fibroblasts cultured in 6-well plates were co-
transfected (FuGene® 6, Roche) with Shh constructs (Shh, ShhC25A, ShhC25S, 
ShhN, or ShhNC25A) over a range of 0.06 ng to 1000 ng in two fold increments, 
pEGFP-C1, a Gli-reporter (pGL3-8xGli-luciferase) (Sasaki et al. 1997; Cooper et 
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al. 2003), pCMV-LacZ, (a transfection control with a 9:1 ratio of Gli-
reporter:LacZ), and variable amounts of empty vector (pcDNA) to normalize the 
total DNA quantity in each well. Shh constructs were eliminated from the co-
transfection mix for controls. Twelve hours later, cells were changed to low-
serum medium (0.5% calf serum) and cultured for an additional forty hours 
(Taipale et al. 2000; Taipale et al. 2002). Time course of reporter activity in 
signaling assays is shown (Figure 4). Cells were then processed by flow 
cytometry, ELISA, or used chemiluminescent signaling assays. Cells from each 
well (9.6 cm2) were harvested and allocated for flow cytometry, Guava EasyCyte 
and ELISA. All experiments were conducted in parallel with identical culture 
conditions. The conditioned medium from each well was also collected for ELISA.  
 In other studies, NIH3T3 cells were transfected with Gli-reporter 
(pGL3-8xGli-luciferase) and pCMV-LacZ (in a 9:1 ratio) changed to low-serum 
medium with exogenous recombinant Shh protein, incubated at 37˚C for 42 
hours, and then analyzed by ELISA or chemiluminescent signaling assays. For 
recombinant Shh protein, HEK293T cells were transfected with a Shh expression 
construct (Shh, ShhC25A, ShhC25S, ShhN, ShhNC25A, or ShhNC25S), and 
changed to low serum medium. Thirty-six hours later, conditioned medium was 
filtered and concentrated (Amicon® Ultra-15 centrifugation filter units; Millipore). 
For control assays, NIH3T3 cells were transfected as above and exposed to 
conditioned medium from untransfected HEK293T cells. 
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Figure 4.	   	  Time course of reporter activity in Shh signaling assays. (A) 
To determine the linear phase of reporter activity (shown to be between 24 
and 48 hours), NIH3T3 fibroblasts were co-transfected with expression 
plasmids for recombinant Shh (125 ng, 15.63 ng, 1.95 ng, and 0 ng), EGFP, 
Gli-reporter and LacZ, changed to low serum medium and assayed at varying 
time points. (B) For signaling assays with conditioned medium, NIH3T3 cells 
were co-transfected with Gli-reporter and LacZ, changed to low serum 
medium containing ShhN protein, and then assayed at the indicated time 
points. Experiments were performed in replicates of three (± s.e.m.).  
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Flow cytometry  
NIH3T3 cells were dissociated with trypsin (Invitrogen) and then washed 
at 4 °C with FACS buffer (phosphate-buffered saline, 2% fetal bovine serum, and 
0.05% sodium azide). Anti-Shh antibody (5E1, Developmental Studies 
Hybridoma Bank) was fluorescently conjugated as directed by the manufacturer 
(Zenon® Alexa Fluor-647; Invitrogen) and cells were then stained with 5E1-Alexa 
Fluor-647 anti-Shh antibody (8 mg/mL diluted at 1:10,000), washed with FACS 
buffer and fixed in 2% paraformaldehyde. To measure total cellular expression 
levels, cells were permeabilized and fixed (BD Cytofix/Cytoperm) prior to 
staining. To measure internal expression, cells were first incubated with a 
saturating level of unlabeled 5E1 antibody (1:50; Figure 5) for 1 hour, washed 
with FACS buffer, and then fixed, permeabilized and stained with fluorescent 
conjugated 5E1 antibody. Samples were run on a 5-laser BD LSRII system (BD 
Biosciences) and at least 50,000 viable cells were analyzed per sample. Non-
viable cells were excluded from analysis based on forward and side scatter 
profiles as well as 7-aminoactinomycin D (Invitrogen) staining. Data were 
acquired using FACSDiva (BD Biosciences) and analyzed using FloJo (Treestar, 
Inc). Both EGFP (excited at 488 nm Argon Laser, and detected with a 505LP 
mirror and a 530/30 bandpass filter) and Alexa 647 (excited at 633 nm He-Ne 
Laser, detected with no LP mirror and a 670/14 bandpass filter) signals were 
analyzed simultaneously in all cells. Mean fluorescence index (MFI) was 
calculated by multiplying the percentage of positively stained cells by the mean 
fluorescence intensity (cells with fluorescence intensity greater than 99% of   
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Figure 5.	   Determination of concentration of unlabeled 5E1 antibody 
required to saturate the cell surface prior to staining with labeled 5E1 
antibody. (A) Total Shh cellular expression: Schematic showing Shh 
transfected cells permeabilized and then stained with labeled 5E1 antibody. 
Internal Shh expression: Schematic illustrating Shh transfected cells first 
incubated with unlabeled 5E1 for cell surface saturation and then permeabilized 
with labeled 5E1. (B) NIH3T3 cells were transfected with Shh cDNA (500 ng) 
and EGFP (1100 ng), while control cells were transfected with EGFP (1100 ng) 
alone.  The cells were then incubated with varying concentrations of unlabeled 
5E1 antibody, fixed, permeabilized, and stained with 5E1 antibody conjugated 
to Alexa 647 (1:10000). Saturation, or capping, of surface staining was 
observed with unlabeled 5E1 antibody over a range of dilutions from 1:50 to 
1:2000.	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control transfected cells (Figure 6 and 7)). For cell counts, NIH3T3 cells were 
suspended in phosphate-buffered saline (PBS) and analyzed with the Guava 
EasyCyte as directed by the manufacturer (Guava® ViaCount® Reagent; Guava 
Technologies).  
 
Enzyme-linked immunosorbent assay (ELISA)  
Culture medium was collected and then NIH3T3 cells were washed three 
times with PBS and lysed in RIPA Buffer (50 mM Tris-HCl at pH 7.4, 150 mM 
NaCl, 2 mM EDTA, 0.1% SDS, 1% NP-40) with protease inhibitors (Complete 
Mini, Roche Applied Science) on a rotator for 4 hours at 4 °C. Recombinant Shh 
protein concentration was measured in the cell lysate and culture medium as 
instructed by the manufacturer (DuoSet® ELISA Development System, R&D 
Systems). ELISA was performed on a series of eight, two-fold dilutions with a 
starting concentration of 1:1 (reagent diluent:sample). The colorimetric optical 
density was measured at 450 nm (FLUOstar Omega, BMG Labtech). An internal 
positive control (purified Shh protein, 0.063 nM) was included in each assay for 
normalization. Culture medium and cell lysate from untransfected NIH3T3 cells 
were used as negative controls.  
 
Shh signaling assays  
Chemiluminescence (Dual-Light® Luciferase and ß-Galactosidase Reporter Gene 
Assay System) was measured in lysed (Passive Lysis Buffer; Promega) NIH3T3 
cells as directed by the manufacturer (FLUOstar Omega, BMG Labtech).  
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Figure 6.	   Representative histograms of total, surface, and internal cell 
staining for Shh.  Shown are histograms for the fluorescent intensity of total 
(A), surface (B), and internal (C) cell staining for Shh within viable EGFP-
positive cells (filled histogram) relative to control cells (unfilled histogram).  	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Figure 7.	   Flow cytometry gating schematic. NIH3T3 cells were co-
transfected with recombinant Shh and EGFP. Non-viable cells and debris 
were excluded from analysis based on forward (FSC) and side scatter 
(SSC) properties and by positive staining for 7-AAD (7-aminoactinomycin 
D), a DNA intercalating agent that permeabilizes dead cells. Shown is an 
example of how Shh expression was determined within EGFP positive 
cells. Mock transfected cells were used as controls.  	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Statistical analysis and data manipulation  
The half-maximal excitatory concentrations (EC50) were determined by 
obtaining the non-linear regression (plotted with a 95% confidence interval) of 
transformed (X=Log(X)) and normalized (highest value set at 100) data. 
Significance was determined using one-way analysis of variance and a 
Bonferroni post-test with 99% confidence intervals. All statistical analyses were 
performed using GraphPad Prism. To determine the cell-associated 
concentrations of recombinant Shh protein in transfected cells, the total amount 
of protein measured in the lysate by ELISA was divided by the number of 
transfected cells (EGFP+) for that well.  
 
Column fractionation, analysis, and sample preparation   
Conditioned media (DMEM with N2 supplement; Invitrogen) from 
recombinant ShhN and ShhNC25S transfected and control (untransfected) 
HEK293T cells were collected, filtered, and then loaded (1 mL loop) on a 15PHE 
Tricorn 5/100 column (GE Healthcare Life Sciences) equilibrated in buffer (3.9 M 
ammonium sulfate, 50 mM Tris pH 8). Prior to loading, samples were brought up 
to a final concentration of 1.5 M ammonium sulfate using a 3.9 M saturated 
ammonium sulfate in ddH2O stock. Bound proteins were eluted after 12 mL wash 
in equilibration buffer by a 70 mL linear salt gradient beginning with 100% 
equilibration buffer at fraction 7 to 100% elution buffer (50 mM Tris pH 8) ending 
at fraction 42. HPLC was performed at 4 °C using the Amersham Biosciences 
ÄKTA Purifier P-900 (GE Healthcare Life Sciences). Fractions were collected in 2 
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mL increments and analyzed by ELISA or by chemiluminescence signaling 
assays.  
 Conditioned medium (DMEM with N2 supplementation; Invitrogen) from 
recombinant Shh (Shh, ShhC25A, ShhC25S, ShhN, ShhNC25A, or ShhNC25S) 
transfected and untransfected control HEK293T cells were collected, filtered, and 
analyzed by HPLC (High Pressure Performance Liquid Chromatography) using 
the Amersham Biosciences ÄKTA Purifier P-900 (GE Healthcare Life Sciences).  
Conditioned medium (400 µL) was fractionated using a Superose 6 10/300 GL 
column (GE Healthcare Life Sciences) equilibrated and ran using PBS with 
0.0001% NP-40. Some experiments described were performed using Superose 
12 10/300 GL and varying amounts of PBS with NP-40 (0.1% NP-40 – 0.0001% 
NP-40). These details are specified in the figure legends. Gel filtration HPLC was 
performed at 4 °C and 0.5 mL fractions were collected. The column void volume 
is 7.5 mL (fraction 8), and elution volumes of gel filtration standards are 12.7 mL 
(fraction 13) for thyroglobulin (669 kDa), 14.5 mL (fraction 14.5) for apoferritin 
(443 kDa), 16.2 mL (fraction 16.5) for alcohol dehydrogenase (150 kDa), and 
18.4 mL (fraction 18.5) for carbonic anhydrase (29 kDa). Elution fractions were 
analyzed by ELISA as described above and confirmed by western blot analysis 
(data not shown). Conditioned medium from HEK293T cells was concentrated 
(Amicon® Ultra-15 centrifugation filter; Millipore) and fractionated using a 
Superose 12 10/300 GL column (GE Healthcare Life Sciences) equilibrated PBS 
with 0.01% NP-40. The 0.5 mL elution fractions containing Shh multimer  (> 29 
kDa) and Shh monomer (< 29 kDa) were pooled, dialyzed (3,500 MW, Slide-A-
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Lyzer Dialysis Cassette; Thermo Scientific) in DMEM and then used in 
chemiluminescence based Shh signaling assays.  
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2.3 Results 
 
Either lipid adduct is sufficient for cellular association of Shh ligand.  
The lipid adducts, cholesterol and palmitate, tightly associate Shh ligand 
with Hh-generating cells (Lee et al. 1994; Porter et al. 1995; Pepinsky et al. 1998; 
Feng et al. 2004). To quantify the contribution of each lipid modification to cellular 
association, NIH3T3 fibroblasts were co-transfected with expression vectors for 
recombinant Shh (ranging from 0.06 ng to 1000 ng in two-fold increments) and 
EGFP, and the concentrations of recombinant Shh protein in culture media and 
cell lysates were measured by ELISA (Figure 8). All the constructs conferred 
similar dose-dependent total expression levels of recombinant forms of Shh 
protein (Figure 9A). The proportions of cell-associated and secreted Shh, 
however, were significantly altered by lipid modification. Whereas only 89.7% of 
lipid-modified Shh was cell associated, virtually all (≥ 99.5%) was released into 
the culture medium when both lipid modifications were removed (ShhNC25A and 
ShhNC25S), indicating a strict requirement of lipid modification for cellular 
association (Figure 9B). Removal of the palmitoyl adduct alone decreased the 
cellular association of recombinant Shh (76.7% of ShhC25A and 56.3% of 
ShhC25S; Figure 9B), and the enhanced association of ShhC25A compared to 
ShhC25S is consistent with the greater hydrophobicity of alanine compared to 
serine (Taylor et al. 2001). Removal of the cholesteryl adduct resulted in the 
retention of 36.5% ShhN (Figure 9B), suggesting a greater contribution of 
cholesterol to cellular association. The efficiency of ShhN palmitoylation,  
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Figure 8.	   Schematics of experimentation. (A) Shh ligand lipidated with 
palmitate and cholesterol was generated from a full-length Shh open reading 
frame.  Point mutation of the amino-terminal C25 to either an A or S was 
introduced to eliminate palmitoylation (ShhC25A, ShhC25S, ShhNC25A and 
ShhNC25S). Introduction of a stop codon after G198 eliminates cholesterol 
modification (ShhN, ShhNC25A, and ShhNC25S). (B) Assays of recombinant 
Shh protein concentration, cellular localization, and signaling were performed 
on transfected NIH3T3 fibroblasts harvested from the same or parallel wells.  
ELISA measurements of Shh protein concentration, flow cytometric analysis of 
cell expression, and chemiluminescence signaling assays in NIH3T3 fibroblasts 
co-transfected with recombinant Shh, EGFP, Gli-reporter, and LacZ were 
integrated to determine the contributions of each lipid adduct on Shh secretion, 
cellular localization, and signaling potency	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Figure 9. Figure legend on following page.  
 	  
 41	  
  
Figure 9. Shh lipid modifications enhance cellular association. (A) 
Each of the constructs conferred dose dependent and similar 
expression levels of recombinant Shh protein.  Shown are the sums of 
protein measurements in cell lysate and culture medium from NIH3T3 
cells transfected with a range of cDNA for Shh, ShhC25S, ShhN, and 
ShhNC25S. (B) Precise quantification of recombinant Shh protein 
concentrations in either the cell lysate or culture medium revealed both 
cholesterol and palmitate modifications confer cellular association. 
Shown are the averages of Shh protein measurements from cells 
transfected with cDNA (62.5 ng to 500 ng in two fold increments). With 
both lipid adducts, 89.7% of Shh was recovered in the lysate and 
10.3% was secreted in the culture medium.  Less protein was 
measured in lysates from cells expressing Shh without a palmitate 
adduct, (76% for ShhC25A and 56.3% for ShhC25S).  Examination of 
the culture medium from cells transfected with ShhN by HPLC  (Figure 
S1) revealed the presence of two species of protein, one that was 
palmitoylated (ShhN+pal) and one that was not (ShhN-pal). 
Approximately 13% of secreted ShhN was palmitoylated (ShhN+pal). 
The portion of cell-associated ShhN (36.5%) represents the ShhN+pal 
species because in the absence of either lipid moiety, less than 0.5% 
of ShhNC25A and ShhNC25S protein was recovered from cell lysate.  
Protein measurements were performed in replicates of four (± s.e.m.) 
*** p<0.001 compared to Shh-transfected cells.   
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however, can be reduced in vitro expression systems (Pepinsky et al. 1998). 
Consistent with this observation, we determined that in our transfection system 
approximately 13% of secreted recombinant ShhN was palmitoylated (ShhN+pal), 
while the remaining secreted protein lacked both cholesteryl and palmitoyl 
adducts (ShhN-pal; Figure 10). Thirty-six percent of recombinant ShhN protein 
was measured in cell lysates, and appears to represent palmitoylated protein 
(ShhN+pal) as less than 0.5% of recombinant Shh protein lacking both lipid 
modifications (ShhNC25A and ShhNC25S) was cell associated (Figure 9B). 
Therefore, in transfected NIH3T3 fibroblasts, approximately 81% of ShhN+pal, 
was cell associated and 19% was secreted. These data demonstrate that either 
lipid modification is sufficient to confer cell association, however, ligand 
quantification by ELISA demonstrates that the palmitoyl adduct provides a 
greater contribution than previously recognized by Western blotting (Feng et al. 
2004).  
 
Cholesterol modification is required for cell surface retention and palmitate 
augments ligand internalization.  	  
The contribution of each lipid adduct to cellular association was 
corroborated by flow cytometric analyses with the anti-ShhN monoclonal 
antibody 5E1 (Ericson et al. 1996). The 5E1 antibody blocks Hh signaling, and 
although 5E1 does not recognize Shh well by Western blotting (Fuse et al. 1999; 
Abe et al. 2008), excellent reactivity (low nanomolar) to the native conformation 
of Shh has been measured by FACS, ELISA, and signaling competition assays 
(Ericson et al. 1996; Pepinsky et al. 2000; Taylor et al. 2001; Bosanac et al.  
 	  
 43	  
  
Figure 10. Two distinct species of recombinant protein in ShhN 
conditioned medium. (A–B) ShhNC25S and ShhN conditioned media were 
subjected to hydrophobic interaction chromatography and collected fractions 
were examined by ELISA.  A single peak of ShhNC25S protein was 
measured in early elution fractions (A). Two peaks of protein were measured 
for ShhN conditioned medium, one that corresponded to Shh protein devoid 
of lipid modifications (ShhNC25S), and a second in later elution fractions 
indicative of greater hydrophobicity. (C–D) ShhN protein in fractions 13 and 
22 was quantified by ELISA and assayed for signaling in NIH3T3 fibroblasts 
transfected with Gli-reporter  and LacZ (± s.e.m.).   
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2009; Maun et al. 2010). Notably, 5E1 binds a surface domain of Shh formed by 
non-continuous residues in the Shh linear sequence that is maintained in the 
absence of either cholesterol or palmitate modification (Pepinsky et al. 2000; 
Bosanac et al. 2009; Maun et al. 2010). Staining with Alexa 647-labeled 5E1 
antibody was performed to detect recombinant Shh protein expression in 
transfected cells (GFP-positive) and neighboring cells (GFP-negative) (Figure 7). 
Total cellular expression was measured in permeabilized cells and surface 
expression was measured in non-permeabilized cells. To detect internal 
expression levels of recombinant Shh protein, non-permeabilized cells were first 
incubated with saturating levels of unlabelled 5E1 antibody, permeabilized, and 
stained with Alexa 647-labeled 5E1 antibody (Figure 5).  
Quantitative flow cytometric analysis of Shh staining within permeabilized 
GFP-positive cells revealed that both lipid adducts are required to confer the 
highest degree of cell association (compare Figure 11D to 11P). 
Correspondingly, we observed a decrement in the percentage of GFP-positive 
cells that expressed ShhC25A (Figure 11G), ShhC25S (Figure 11J), and ShhN 
(Figure 11M). These findings were reiterated by examining total cell expression 
levels over a range of recombinant Shh expression in GFP-positive cells (Figure 
12A), and are consistent with an interpretation of the ELISA studies that either 
lipid moiety can confer cell association. Yet, distinct contributions of the palmitoyl 
and cholesteryl adducts to steady state cell distribution were revealed. Surface 
expression was retained in the absence of the palmitoyl adduct (ShhC25A and 
ShhC25S; Figures 11H, 11K, 11T and 11B). Without the cholesteryl adduct, only  
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Figure 11. Figure legend on following page.  
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Figure 11. Cholesterol is required for expression of Shh on the 
cell surface.  Shown are flow cytometric data from NIH3T3 
fibroblasts co-transfected with recombinant Shh variants (0.125 ng) 
and EGFP (1000 ng), and stained with 5E1-Alexa 647 conjugated 
antibody. Total cell staining was measured in permeabilized cells and 
surface staining was measured in non-permeabilized cells. Internal 
staining was measured in cells that were pretreated with a saturating 
level of unlabeled 5E1 antibody prior to permeabilization and staining 
with 5E1-Alexa 647. Scatter plots (A–R) and histograms (S–X) of 
5E1-Alexa 647 staining in transfected (GFP-positive) and 
untransfected (GFP-negative) cells revealed that cholesteryl 
modification is required for surface expression (compare E, H & K to 
N & Q and T to W). In Shh transfected cells (GFP+/5E1-Alexa 647+) 
and untransfected cells (GFP-/5E1-Alexa 647+), the highest ligand 
staining levels are measured with fully lipidated Shh (D).  Removal of 
either lipid moiety results in decreased cellular retention (G, J, M, P). 
Shh surface expression (E) is reduced in the absence of palmitate 
(H, K) and eradicated by the removal of cholesterol (N, Q). Internal 
expression is also diminished in the absence of either lipid moiety (F, 
I, L, O, R). Histograms of the number of 5E1-Alexa 647-positive cells 
within GFP-positive or GFP-negative cells reiterate the above 
findings (S-X). Experiments were done in replicates of two or more 
and representative images are shown.  	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2.9% of total Shh was available on the cell surface while the removal of both lipid 
adducts entirely eliminated surface expression (Figure 12D). Further, the 
percentage of cell-associated ligand localized to the surface was not significantly 
altered by removal of the palmitate (Figure 12D), indicating that the cholesteryl 
adduct alone is sufficient for cell surface expression and the palmitoyl adduct 
alone strongly enhances internal cellular localization (Figure 13). Supporting a 
requirement of cholesterol for localization to the plasma membrane, its removal 
(ShhN and ShhNC25A) virtually abolished surface staining (Figures 11N, 11Q, 
11T, 12B and 12D). Additionally, the highest internal levels of recombinant Shh 
were measured within ShhN-transfected cells (Figure 12C). In conjunction with 
the ELISA data revealing that the ShhN+pal species is cell associated, these data 
indicate that in the absence of a cholesterol tether to the cell surface the 
palmitoyl adduct strongly enhances ligand internalization (Figure 13, note that 
78.6% of ShhN+pal is expressed inside cells).  
Analysis of 5E1 staining in GFP-negative fibroblasts suggests that lipid 
modification serves analogous functions in receiving cells. In Shh-transfected 
fibroblasts, 5E1 staining was measured in a significant population of GFP-
negative cells (Figure 11D and 11V-11X) and was largely confined to the cell 
surface (compare 11E to 11F). Conversely, staining in GFP-negative cells was 
markedly reduced in the absence of both lipid adducts (ShhNC25A; Figure 11P-
11R and 11V-11X). Thus, lipid modification strongly enhances ligand association 
with receiving cells. When solely modified by cholesterol (ShhC25A and 
ShhC25S), a similar population of GFP-negative cells stained with 5E1 antibody 
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Figure 12.  Figure legend on following page. 
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Figure 12. Distinct properties of cholesterol and palmitate modification 
on cellular localization of Shh ligand.  (A–E) Distinct influences of the 
cholesterol and palmitate modifications on Shh cellular localization were 
revealed by quantification of mean fluorescence indices (MFI) for 5E1-Alexa 
647 staining of NIH3T3 fibroblasts co-transfected with recombinant Shh (0.06 
ng to 1000 ng) and EGFP (1050 ng).  (A–C) In transfected cells (GFP+), 
removal of both lipid adducts greatly diminished total cell MFI (compare 
ShhNC25A to Shh in A), and abolished surface expression (compare 
ShhNC25A in B and C).  In ShhN transfected cells, where the vast majority of 
cell associated recombinant ligand appears to represent a palmitoylated 
species (ShhN+pal), surface expression was greatly diminished and 
concomitantly internal expression was enriched (compare ShhN in A, B & C).  
Conversely, following removal of the palmitate alone (ShhC25A & ShhC25S) 
surface expression was maintained (B) while internal expression levels were 
reduced to that of recombinant ligand lacking any lipid-modification (compare 
ShhC25A and ShhC25S to ShhNC25A in C).  (D) To quantify the amount of 
cell-associated Shh ligand that was expressed on the surface, the MFI for 
internal staining was subtracted from that for total cell staining.  Removal of 
both lipid adducts eliminates surface expression, and only 2.9% of cell-
associated ShhN (ShhN+pal) was localized to the cell surface. (E) 
Correspondingly, surface staining with 5E1-Alexa 647 in untransfected cells 
(GFP-) was only measureable for recombinant Shh with cholesterol 
modification (Shh, ShhC25A, & ShhC25S). Control cells were mock 
transfected, and MFI is shown relative to control.  Experiments were done in 
replicates of two or more and representative images are shown.  NS, not 
significant (p>0.05); ***, p<0.001 (± s.e.m.) compared to Shh transfected 
cells.    
 	  
 50	  
  
Figure 13.	  Quantification of the contributions of the lipid moieties 
to cellular distribution of Shh.  Shown are integrated data from 
ELISA and flow cytometric measurements of recombinant forms of Shh 
expressed inside cells, on the cell surface, or secreted in the culture 
medium.  The proportion of cell associated and secreted Shh protein for 
each recombinant expression construct was determined by ELISA 
measurements of cell lysate and conditioned medium in cells 
transfected with two fold increments of 62.5-500 ng cDNA (Figure 9B).  
From the same culture wells, the percentage of Shh protein expressed 
on the surface and within cells was determined by flow cytometric 
measurements (Figure 12).  To determine the proportion of surface 
protein expression, the quantity of cell associated Shh was multiplied 
by the percentage expressed on the cell surface as calculated in Figure 
12D.  The remaining cell associated Shh protein represents the internal 
proportion for each recombinant construct.  ***, p<0.001; *, p<0.05  (± 
s.e.m.)   
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(Figure 11V-11X) and surface localization of ligand predominated (Figure 11G-
11L). These results support mathematical modeling studies that postulate that 
cholesterol is the predominant lipid determinant for cell surface association (Saha 
and Schaffer 2006). Notably, surface staining in GFP-negative cells was 
measurable only for cholesterol modified Shh ligands (Figure 12E). The mean 
fluorescence indices (MFI) for ShhC25A and ShhC25S surface staining were 
higher than for Shh in GFP-negative cells as a consequence of the higher levels 
of cholesterol modified ligand in the culture media under these conditions (Figure 
9B). Furthermore, the enhanced surface MFI of ShhC25A with respect to 
ShhC25S is consistent with the greater hydrophobicity of alanine compared to 
serine (Taylor et al. 2001). 
 
Lipid modifications dictate cell concentration and signaling potency of Shh 
ligand.  
 
The evaluation of 5E1 staining in GFP-negative cells supports a 
predominant role for cholesterol modification in the association of recombinant 
Shh ligand with target cells. To directly test the influence of the lipid modifications 
on ligand association with receiving cells, NIH3T3 fibroblasts were exposed to 
varying quantities of recombinant Shh protein, and the corresponding amounts of 
cell-associated ligand was measured by ELISA (Figure 14). By this assay, the 
highest degrees of cellular association were observed following incubation with 
fully lipid-modified Shh. Removal of both lipid adducts (ShhNC25S) greatly 
diminished recovery of ligand in the cell lysate and ShhN+pal and ShhC25S 
demonstrated equivalent dose-dependent cellular association. Collectively, these  
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Figure 14.	   Lipid modification enhances Shh 
association with receiving cells.  NIH3T3 cells were 
incubated at 37 ºC for 42 hours with medium 
containing various concentrations of recombinant Shh 
protein. After extensive washes, the cells were lysed 
and analyzed by ELISA. The highest levels of protein 
were recovered from cell lysates following incubation 
with Shh-conditioned medium. Recovery of ligand 
was greatly diminished when both lipid adducts were 
removed (ShhNC25A), and restored with either 
cholesteryl (ShhC25S) or palmitoyl (ShhN+pal) 
modification alone.  Experiments were performed in 
replicates of four, and representative data are shown.	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data provide direct evidence that the lipid modifications are essential for 
association with target cells.  
 There are conflicting reports regarding the roles of lipid modification and 
ligand signaling. The signaling potency of Shh ligand devoid of cholesteryl and 
palmitoyl adducts in C3H10T1/2 cells can be enhanced by the introduction of a 
wide variety of hydrophobic modifications (Taylor et al. 2001). Conversely, 
several studies have reported that removal of either the cholesteryl or palmitoyl 
adduct abolishes ligand multimerization and signal response in NIH3T3 
fibroblasts (Zeng et al. 2001; Chen et al. 2004; Goetz et al. 2006). We analyzed 
NIH3T3 cells, which have been used most commonly for Hh signaling assays 
(Taipale et al. 2000; Zeng et al. 2001; Cooper et al. 2003; Chen et al. 2004; 
Goetz et al. 2006), and found that signal response was greatly reduced in cloned 
and high-passage lines (Figure 15). As reported, removal of either lipid adduct 
eliminates the detection of multimeric Shh protein complexes (Figure 16). 
However, using low-passage and highly responsive NIH3T3 fibroblasts, 
measurable signaling was retained by each of the recombinant forms of Shh 
ligand (Figures  17 and 18), and thus multimerization is not required to generate 
a signal response. To directly test the effect of multimerization on signaling, 
conditioned medium from HEK293T cells transiently transfected with Shh was 
subjected to size exclusion chromatography. Purified multimer and monomer 
elusion fractions were then pooled and Gli reporter activity was measured. Our 
data suggest that signal potency of Shh conditioned medium does not reside in 
the multimeric fraction. Instead, multimer and monomer have roughly equivalent  
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Figure 15.	   Variable signaling responses among lines of NIH3T3 
fibroblasts. (A) NIH3T3 cells stably transfected with Gli-reporter and LacZ 
(Shh LIGHT Z3 cells) {Cooper, 2003 #34} exhibited a dose dependent, but 
low response to Smoothened Agonist (SAG).  (B-C) Three different NIH3T3 
cell lines transiently transfected with Gli-reporter and LacZ demonstrated 
marked differences in signaling competency with pathway activation by co-
transfection with Shh (B), the addition of ShhN conditioned medium, or SAG 
(C).  Shh LIGHT Z32 cells and lines 1 and 2 were maintained and passaged 
over long periods of time.  Line 3 was newly purchased from ATCC and 
expanded in culture over one passage.  Fresh aliquots of cryopreserved cells 
from line 3 were used in all of the experiments in this study.  Experiments 
were performed in replicates of three (± s.d.).   
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Figure 16.	   Both lipid adducts are required for multimerization.  
HEK293T cells were transfected to express Shh, ShhC25A, ShhC25S, 
ShhN, or ShhNC25A, and then cultured in serum-free media for 48 hours.  
Conditioned media (400 µL containing 4.3 ng to 363.3 ng of recombinant 
Shh) was then subjected to size exclusion chromatography.  Collected 
fractions were then analyzed by ELISA, and the percentage of 
recombinant Shh protein in each fraction relative to the total amount 
eluted is shown.  Recombinant protein was detected in the high molecular 
weight fractions (elution volumes 15ml to 18ml, estimated mass 450kDa 
to 50kDa) only in the Shh-conditioned medium, thus both lipid adducts 
are needed for multimer formation.   
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Figure 17.  Figure legend on following page.
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Figure 17.	   Shh signaling potency is directly related to cellular 
concentration of ligand. NIH3T3 fibroblasts were co-transfected with 
expression plasmids for recombinant Shh (Shh, ShhC25S, ShhN, or 
ShhNC25S), EGFP, Gli-reporter (8xGli-luciferase) and LacZ, changed to low-
serum medium for 40 hours, and then analyzed for chemiluminescence.  (A–D) 
Shown are relative luciferase values as a function of transfected recombinant 
Shh cDNA.  ShhNC25A signaling was significantly reduced in comparison to 
Shh, ShhC25S, and ShhN.  (E–H) Analysis of relative luciferase activity as a 
function of recombinant ligand expressed per transfected cell (pg/cell) revealed 
that all of recombinant forms of Shh signaled with equal potency.  Solid line 
denotes non-linear regression and the dotted lines denote confidence intervals 
of 95%.  Experiments were performed in replicates of three (± s.e.m.). 
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signaling potency (Figure 19). (See Appendix section A2.1 and figures A1, A2, 
and A7 for further discussion.) 
In order to determine whether levels of cell-associated ligand correlate 
with signal response, parallel wells of low-passage and highly responsive 
NIH3T3 fibroblasts co-transfected with expression vectors for recombinant Shh, 
GLI-reporter, and EGFP were assayed. In one set of wells, relative GLI-reporter 
activity was measured and in the other set the concentration of recombinant 
ligand was determined within GFP-positive cells. When signaling activity was 
expressed relative to transfected DNA for recombinant Shh, signaling levels were 
comparable for Shh, ShhC25S, and ShhN and markedly reduced for ShhNC25S 
(Figure 17A-17D). Yet, when expressed relative to the cellular quantity of ligand, 
the half-maximal effective concentrations (EC50) for each of the recombinant 
ligands, including ShhNC25S, were nearly identical (Figure 17E-17H and Table 
1). The concentrations of recombinant variants of Shh protein recovered from the 
culture medium was well below the respective EC50 calculated in conditioned 
medium signaling assays, indicating that signaling was mediated by cell-
associated ligand in the transfection assays (see Figure 18 and compare Table 1 
and Table 2). (See Appendix section A2.1 and figures A4-A6 for discussion of 
Shh(n-5)). These data strongly support a direct relationship between signaling 
potency and cellular concentration of ligand.  
When signaling was measured for ligand delivered exogenously to 
NIH3T3 fibroblasts, the maximal signaling level was highest with Shh and 
diminished by removal of one or both of the lipid adducts  
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Table 1.  Relative signaling potencies of recombinant forms of Shh ligand.  
The half maximal effective concentration (EC50) of Shh and recombinant variants 
lacking one or both lipid modifications was determined in signaling assays with 
NIH3T3 fibroblasts that were either transfected with recombinant Shh, or to which 
Shh conditioned medium was added exogenously.  ND, not determined.   
 
  
Recombinant Shh Cell transfection Conditioned Media 
 EC50 (pg/cell) Relative to Shh EC50 (nM) Relative to Shh 
Shh 0.0017 1 0.81 1 
ShhC25A 0.0077 4.5 5.04 6.2 
ShhC25S 0.0026 1.6 7.71 9.5 
ShhN 0.00093 0.6 ND ND 
ShhNC25A ND ND 311 384 
ShhNC25S 0.0031 1.8 104.1 128.5 
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Table 2. Concentration of recombinant Shh in culture medium from 
signaling assays in transfected NIH3T3 fibroblasts.  Shown is the amount of 
recombinant Shh protein measured by ELISA in the culture medium from 
transfected NIH3T3 fibroblasts.  The concentrations of recombinant Shh protein 
recovered in the culture media are well below the EC50 measured for each type 
of variant when added exogenously to NIH3T3 cells.   
  
Transfected DNA (ng) 500 250 125 62.5 
Shh (nM) 0.044 0.035 0.029 0.0085 
ShhC25S (nM) 0.59 0.23 0.14 0.11 
ShhN (nM) 0.17 0.078 0.03 0.012 
ShhNC25S (nM) 0.92 0.43 0.23 0.11 
 	  
 61	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18. Figure legend on following page.   
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Figure 18.	   Lipid modification enhances signaling 
potency of Shh. NIH3T3 fibroblasts were co-transfected 
with Gli-reporter and LacZ, and changed to low-serum 
medium containing Shh, ShhC25A, ShhC25S, ShhN, 
ShhNC25A, or ShhNC25S protein. (A–F) Shown are relative 
luciferase values as a function of Shh protein (nM) added. 
(G–K) Normalized relative luciferase measurement of the 
Log EC50 for each variant of recombinant Shh revealed 
decreased signaling potency following removal of one or 
both lipid adducts. An EC50 could not be calculated for 
ShhN-conditioned medium because of the complex signaling 
curve (D). Solid lines denote non-linear regression, and the 
dotted lines denote confidence intervals of 95%. 
Experiments were performed in replicates of three (± s.e.m.)  
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Figure 19.	   Multimeric and monomeric forms 
of Shh signal with similar potency. 
Conditioned medium from HEK293T cells 
transfected with Shh were cultured in serum-free 
medium for 48 hours.  Conditioned medium (600 
µL containing 753 ng of recombinant Shh) was 
subjected to size exclusion chromatography 
using a Superose 12 10/300 GL column, and 
purified elution fractions containing Shh multimer 
and monomer were pooled, dialyzed in DMEM, 
and quantified by ELISA. Shh signaling was 
measured by chemiluminescence in triplicate 
wells of NIH3T3 cells transfected with Gli-
reporter (8xGli-luciferase).  p>0.05  (± s.e.m.) 
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(ShhC25A>ShhN>ShhNC25A; Figure 18A-18E). The complex signaling curve 
measured for ShhN negated the ability to calculate an EC50 in this instance, 
possibly because of the presence of two species of ligand (ShhN+pal and ShhN-
pal). However, separation of ShhN+pal from ShhN-pal in ShhN conditioned medium 
by hydrophobic interaction chromatography revealed that ShhN+pal elution 
fraction contained the highest signaling potency (Figure 10). Furthermore, the 
EC50 calculated for Shh, ShhC25A, and ShhNC25A correlate directly with 
measurements of their cell-association properties (Figure 14), supporting the 
conclusion that the lipid modifications regulate Shh ligand association with 
receiving cells and dictate signaling potency. 
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2.4 Discussion 
 
Hedgehog proteins are among several secreted signaling proteins that are 
covalently modified by lipid moieties (Reviewed in (Steinhauer and Treisman 
2009)). Hedgehog family members are the only proteins that are known to be 
modified by cholesterol (Porter et al. 1996b), and this discovery cultivated 
attention on the influences of lipids on morphogen signaling (Reviewed in (Eaton 
2008)). The influences of the lipid modification on ligand release and association 
with multivalent particles have been well characterized (Lee et al. 1994; Porter et 
al. 1995; Zeng et al. 2001; Feng et al. 2004; Panakova et al. 2005). The roles of 
the lipid adducts in signal response have been less well defined, however, in part 
due to constraints of in vivo model systems to distinguish effects on tissue 
distribution from signal potency (Lewis et al. 2001; Chen et al. 2004; Li et al. 
2006; Huang et al. 2007) and of in vitro systems with poorly responsive cell lines 
and qualitative assays of ligand concentration (Zeng et al. 2001; Chen et al. 
2004; Goetz et al. 2006). Utilizing highly responsive NIH3T3 fibroblasts and 
quantitative assays to integrate measurements of recombinant Shh 
concentration, cellular localization, and signaling, we demonstrate that the 
membrane-anchoring properties of cholesterol and palmitate govern the cellular 
reception of Shh and that signaling potency correlates directly with cellular 
concentration of Shh ligand. In conjunction with prior studies, these findings 
illustrate complementary functions of the lipid modifications to attenuate release 
and enhance reception of Shh signal.  
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Our studies indicate that either lipid moiety is sufficient to enhance cellular 
association and increase signaling potency. Cholesterol modification, however, 
tethers ligand to the plasma membrane while palmitoylation alone is not sufficient 
for retention on the cell surface. These distinct properties identified in our in vitro 
assays may explain opposing and seemingly puzzling effects on limb patterning 
observed in prior in vivo studies following expression of Shh lacking either the 
palmitoyl or cholesteryl adduct in the zone of polarizing activity (ZPA). In the 
mouse limb bud, digit number is reduced by targeted deletion of Skinny 
Hedgehog (Skn) to abrogate Shh palmitoylation, the finding interpreted to 
indicate a requirement for a multimeric Shh protein complex in long range 
signaling (Chen et al. 2004). Long range signaling, however, is enhanced by 
removal of the Shh processing domain to eliminate cholesterol modification, 
indicating that cholesterol restricts the long-range movement of Shh protein 
across the limb bud (Li et al. 2006). In both instances, removal of either 
cholesterol or palmitate disrupts Shh multimerization (Zeng et al. 2001; Chen et 
al. 2004). Therefore, our data suggest that the defects in digit specification in 
Skn-/- limb buds (Chen et al. 2004) are consistent with Shh protein secreted from 
the ZPA with reduced potency, resulting from absence of palmitoylation, and 
restricted long-range movement, due to cholesterylation. Conversely, in limb 
buds engineered to express ShhN in the ZPA (Li et al. 2006), ligand with reduced 
potency is distributed more broadly due to the absence of cholesterol anchorage 
to implement low-threshold signaling in the anterior limb bud. Collectively, these 
observations support a model whereby multimeric or multivalent Shh complexes 
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are not strictly required for Shh signaling, but rather represent a mechanism for 
delivering soluble and potent lipidated ligand over a range of cells during tissue 
patterning. 
In the absence of Shh ligand, Ptc1 functions to inhibit the pathway by 
suppressing the activity of the transmembrane protein Smoothened (Smo) 
(Taipale et al. 2002). Upon binding with Shh, Ptc1 inactivation allows Smo to 
initiate signaling (Marigo et al. 1996; Stone et al. 1996; Fuse et al. 1999) through 
the Gli family of transcription factors (Reviewed in (Ingham and McMahon 2001)). 
In vertebrates, primary cilia appear to be the principal site where Shh signaling is 
regulated by reciprocal subcellular localizations of Ptc1 and Smo (Huangfu and 
Anderson 2005; Rohatgi et al. 2007). According to this model, Ptc1 localized to 
the base of primary cilia inhibits the lateral transport of Smo, and binding of Shh 
to Ptc1 activates signaling by reciprocal movement of Ptc1 out of the cilium and 
Smo into the cilium (Rohatgi et al. 2007; Milenkovic et al. 2009). Ptc1 function 
and the dynamics of its subcellular localization are not fully understood. Sub-
stoichiometric levels of Ptc1 suffice to regulate Smo, and the levels of free Ptc1 
protein determine the degree of pathway activity as well as the amount of Shh 
ligand required for pathway stimulation (Taipale et al. 2002). Ptc1 expression is 
increased by pathway activation (Goodrich et al. 1997). In NIH3T3 fibroblasts, 
endogenous Ptc1 is barely detectable by immunofluorescence, and upon 
pathway activation becomes highly enriched in primary cilia (Rohatgi et al. 2007). 
Against this background, our data may clarify the observation in cell-based 
assays that lipophilic modification of Shh enhances signaling potency without 
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affecting binding affinity for Ptc1 (Pepinsky et al. 1998; Williams et al. 1999; 
Taylor et al. 2001). Notably, binding assays were performed with cells 
transfected with a Ptc1 construct truncated at the carboxy-terminal domain to 
enhance surface expression (Stone et al. 1996; Pepinsky et al. 1998; Williams et 
al. 1999; Taylor et al. 2001). We measured a profound reduction in signaling 
potency and corresponding curtailment in cellular association of unmodified Shh 
(ShhNC25S and ShhNC25A), suggesting that anchorage of Shh ligand to target 
cells by lipid modification is critical for access to Ptc1 and other receptor complex 
proteins. This concept raises the intriguing notion that the lipid modification may 
also serve to create a reservoir of membrane-associated ligand to maintain 
durable signaling as cellular levels of Ptc1 are increased. As such, the tethering 
of Shh ligand to receiving cells could directly influence the temporal and spatial 
gradients of Shh signaling (Briscoe et al. 2001; Harfe et al. 2004; Dessaud et al. 
2007). 
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CHAPTER III 
 
 
GENERATION OF VISUALIZABLE SHH AND CREATION OF SHH-EGFP 
TRANSGENIC ZEBFRAFISH 
 
 
3.1 Introduction 
 
Within a developing organism, discrete cellular centers secrete diffusible 
signals that specify cell fate within neighboring cells. These factors are thought to 
signal in a concentration dependent manner and are called morphogens (Roelink 
et al. 1995). Shh is secreted from midline structures in the ventral neural tube 
(VNT), the notochord, and adjacent floorplate, and is among several signaling 
morphogens to pattern a field of progenitor cells within the neural ectoderm, 
neighboring mesoderm, and endoderm (Krauss et al. 1993; Roelink et al. 1994; 
Roelink et al. 1995; Teleman et al. 2001). Proper ligand distribution is thus 
essential to obtain a full range of graded responses, and so it is notable that 
during protein biogenesis the secreted signaling domain of Shh is covalently 
modified by cholesterol and palmitate adducts (Porter et al. 1996b; Pepinsky et 
al. 1998). Determining the detailed roles of the lipid modifications in Shh cellular 
packaging and handling is paramount to understanding Shh long-range signaling.  
To aid our studies on Shh protein propagation and reception, as described 
in Chapter II, and to learn how a morphogen with unique biochemical properties 
is trafficked and patterns neural tissues, we generated a visualizable form of the 
ligand to use in cell culture studies and in generation of a transgenic zebrafish 
model. Using the Gal4-UAS system to drive tissue specific Shh expression, we 
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created transgenic lines of zebrafish containing genomic sequences that regulate 
Shh-EGFP temporal and spatial expression within the notochord and floor plate. 
We also generated transgenic lines of Hh protein lacking a palmitoyl or 
cholesteryl adduct (zShhC24S-EGFP and zShhN-EGFP respectively).  
When we started this project, a Shh gradient had never been visualized in 
vivo. Since then, however, studies in murine and Drosophila have both visualized 
fluorescently labeled Hh in the neural tube or imaginal wing disc (Torroja et al. 
2004; Chamberlain et al. 2008). These studies and others confirm the existence 
of a Shh gradient in the VNT and demonstrate that Shh is concentrated in large 
puncta in an apical region of ventral midline cells over the notochord (Huang et 
al. 2007; Chamberlain et al. 2008). Furthermore, live imaging by confocal 
microscopy demonstrates that fluorescently labeled Shh colocalizes with the 
cilium, concentrating at the base. Hh is also observed associating with 
microtubules (Chamberlain et al. 2008).  
Nonetheless, we generated transgenic zebrafish effector lines (Tg[UAS-
zShh-EGFP] and Tg[UAS-zShhC24S-EGFP]) and driver lines (Tg[arB/C-
Shh:Gal4-VP16]) that specifically drive Shh expression in the notochord and floor 
plate. The optical clarity of zebrafish embryos allows for real-time fluorescence 
imaging of individual cell behaviors, making them more advantages than murine 
models for these sorts of experiments. We planned to determine the contribution 
of the palmitoyl adduct on ventral neural tube patterning and ligand distribution. 
We hypothesized that disruption of ventral neural tube patterning, but not the 
propagation of GFP-tagged ligand, by expression of ShhC24S-EGFP in the floor 
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plate of wild-type zebrafish embryos, would constitute strong evidence that the 
palmitoyl adduct is required for cell non-autonomous response. 
Though we were not able to complete these studies and have since 
determined that the palmitoyl adduct is involved in cellular reception and Shh 
internalization (Chapter II), these transgenic lines can still be used to further 
understand the role of the palmitoyl adduct in vivo. Furthermore, in zebrafish, the 
primary cilium is influential in early development and its absence affects maximal 
Shh signaling (Aanstad et al. 2009; Huang and Schier 2009). It would be 
interesting to examine the role of the lipid adducts on Shh trafficking in the 
context of the primary cilium.  
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3.2 Materials and Methods 
 
Cell culture and transfection 
 Co-transfection assays: NIH3T3 mouse embryonic fibroblasts were 
cultured in 6-well plates and co-transfected (FuGene® 6, Roche) with one of the 
four recombinant Shh fusion constructs (ShhN51-EGFP, ShhK66-EGFP, 
ShhK69-EGFP, or ShhA193-EGFP), a Gli-reporter (pGL3-8xGli-luciferase) 
(Sasaki et al. 1997; Cooper et al. 2003), and pCMV-LacZ, (a transfection control 
with a 9:1 ratio of Gli-reporter:LacZ). Twelve hours later, cells were changed to 
low-serum medium (0.5% calf serum) and cultured for an additional forty hours 
(Taipale et al. 2000; Taipale et al. 2002). Cells were then used in 
chemiluminescent signaling assays. Luciferase activity was normalized to β-
galactosidase activity and data are shown relative to control vector (EGFP). 
 Co-plating assays: In these studies, NIH3T3 cells were transfected 
with one of the four recombinant Shh fusion constructs (ShhN51-EGFP, ShhK66-
EGFP, ShhK69-EGFP, or ShhA193-EGFP) and co-plated with Shh Light Z32 
cells (cells stably transfected with Gli-reporter and LacZ), changed to low-serum 
medium, incubated at 37˚C for approximately 40 hours, and then analyzed by 
chemiluminescent signaling assays. Luciferase activity was normalized to β-
galactosidase activity and data are shown relative to control vector (EGFP). 	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Shh signaling assays  
Chemiluminescence (Dual-Light® Luciferase and ß-Galactosidase 
Reporter Gene Assay System) was measured in lysed (Passive Lysis Buffer; 
Promega) NIH3T3 cells as directed by the manufacturer (FLUOstar Omega, 
BMG Labtech) .  
 
Western blot analysis 
NIH3T3 mouse embryonic fibroblasts were transiently transfected with a 
Shh fluorescently labeled (FL) construct and following 24 hours in culture, cell 
lysates were immunoprecipitated with an anti-GFP monoclonal antibody, 
separated by SDS-PAGE and probed with either an anti-GFP polyclonal antibody 
(1:1000) (used in Figure 22) or an anti-Shh antibody (JH134 1:1000) (not shown).  
 
In situ RNA hybridization 
 In situ hybridization was performed as described (Hauptmann and Gerster 
2000). Previously described RNA probes, shh (Krauss et al. 1993) were also 
used. Images were collected as demonstrated (Park et al. 2004). 
 
Molecular cloning 
Zebrafish Shha (zShh/Shha) coding sequence was obtained from zShh 
T7TS vector (Ekker et al. 1995) and EGFP coding region was isolated from 
pEGFP-C1 (Clontech). A non-helical oligopeptide linker (NH), APAETKAEPMT 
(George and Heringa 2002), was inserted between zShh and EGFP sequences. 
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After rigorous functional studies demonstrating that Shh-NH-EGFP was both 
processed correctly and retained signaling capabilities, EGFP was added in 
between zShh Ala 192 and Ala 193. Two unique restriction enzyme sites, Nhe I 
and Xho I, were introduced flanking NH-EGFP sequence and between zShh 
A192 and A193 and were used to insert NH-EGFP in frame into the coding 
region of zShh (Figure 24). UAS-GFPpA fragment was obtained from UG (Koster 
and Fraser 2001) as described in (Inbal et al. 2006). Using pT2-UAS-GFP-γ-Cry-
GM2 described in (Inbal et al. 2006), GFP was released and zShh-NH-EGFP 
construct described above was inserted between UAS and pA using Kpn I and 
Apa I restriction sites. pT2-arB/C-Shh:Gal4-VP16 uses ar-B and ar-C intronic 
enhancer regulatory sequences to control zShh temporal and spatial expression 
within the floor plate and notochord (Muller et al. 1999) (Figure 24). Gal4-VP16 
coding sequence was obtained and inserted as described (Inbal et al. 2006). 
 
Generation of pT2-UAS-zShhNH-EGFPγ-Cry-GM2 and pT2-Gal4VP16-arB/C-
zShhγ-Cry-GM2 transgenic zebrafish 
 
Transgenesis was performed using the Sleeping Beauty transposon 
system and transgenes were cloned into the pT2/γ-Cry-GM2 vector (Davidson et 
al. 2003). DNA constructs were co-injected with SB10 transposase capped RNA 
into 1-cell stage embryos and raised to adulthood. Transgenic lines were 
generated as described (Inbal et al. 2006).  
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Immunohistochemistry and live imaging 
 Embryos were fixed in 4% paraformaldehyde in phosphate-buffered saline 
and both live and fixed tissue were imaged using Zeiss LSM 510 laser scanning 
inverted microscope and processed using ImageJ. Rabbit polyclonal alpha-GFP 
antibody at 1:500 (Torrey Pines Biolabs) and Cy2 conjugated goat anti-rabbit 
antibody at 1:150 (Abcam).  
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3.3 Results 
 
Generation of Shh-EGFP chimeric proteins 
To gain mechanistic insight into how the Shh lipid modifications affect its 
cellular packaging, handling and trafficking, we generated a visualizable form of 
the ligand. Fourteen putative sites to insert enhanced green fluorescent protein 
(EGFP) were chosen based on the protein structure of Shh (Hall et al. 1995) as 
well as mutagenesis studies performed that altered the Ptc binding domain (Fuse 
et al. 1999). EGFP was inserted at surface residues to minimize protein-folding 
errors. For each site, EGFP sequences were introduced in frame into full length 
Shh cDNA to retain the autoprocessing domain and allow for full lipid 
modification. These recombinant Shh-EGFP fusion constructs were tested and 
screened for the ability to undergo autoprocessing and signaling.  
 
Determining Shh-EGFP signaling and autoprocessing 
Using two distinct Shh signaling assays, a co-plating and a co-transfection 
assay, we measured whether Shh-EGFP was able to retain both autocrine and 
paracrine signaling. Four of the fourteen Shh-EGFP constructs, (ShhN51-EGFP, 
ShhK66-EGFP, ShhR69-EGFP, and ShhA193-EGFP) (Figure 20), retained Shh 
signaling. In the co-transfection assay, using NIH3T3 mouse embryonic 
fibroblasts, recombinant Shh-EGFP fusion construct was co-transfected with 
CMV promoter driven LacZ (a transfection control), and a Shh reporter construct 
(pGL3-8xGli-luciferase) that drives luciferase expression upon pathway activation 
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Figure 20.	   Mus musculus structure of Shh indicating EGFP 
insertion sites used to generate fluorescently conjugated Shh 
constructs. Shown are two different structural orientations 
illustrating four sites (ShhN51, ShhK66, ShhK69, and ShhA193) 
where EGFP was inserted. All four of the recombinant DNA fusion 
constructs retained signaling. 
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(Taipale et al. 2002). This assay tests Shh biogenesis and Ptc receptor binding 
(Figure 21 A and B). All recombinant Shh-EGFP constructs retained autocrine 
signaling, thus presumably they were able to bind Ptc. In the co-plating assay, 
NIH3T3 cells transfected with one of four Shh-EGFP constructs, were coplated 
with mouse embryonic fibroblast cells that stably express the Shh reporter 
construct and LacZ (Light Z32). This second assay, in addition to Ptc receptor 
binding and Hedgehog biogenesis, also more readily measures secretion and 
reception (Figure 21 A and C). ShhA193-EGFP retained robust signaling 
capacity in both assays. We did not control for protein concentration in this assay 
and cannot definitively make any conclusions about the various levels of Shh 
signaling. Due to the drastic differences in signaling, the results from the co-
plating assay are interesting nonetheless. The mutant Shh fusion constructs in 
which EGFP was added in proximity to the amino terminus of the signaling 
domain, showed diminished signaling, even though all bound to Ptc with equal 
affinity. This aberration in signaling could simply be because Light Z32 cells are 
not very responsive to Shh (discussed in detail in Chapter II), the local 
concentration was not sufficient resulting in diminished Shh cellular association 
and signaling, or they were not processed or secreted efficiently. Additionally, 
these amino terminal Shh-EGFP constructs may have diminished binding to 
heparin sulfate proteoglycans (HSPG). HSPGs influence Shh signaling and 
trafficking and are thought to interact with Shh via the Cardin-Weintraub (C-W) 
domain (a region on the Shh amino terminus) that binds heparin (Rubin et al. 
2002; Chan et al. 2009). Perhaps conformational changes altering the C-W  
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Figure 21.	  Cell-based Shh signaling assays. (A) Schematic of 
signaling assays in NIH3T3 fibroblasts.  In one assay, cells 
transfected with Shh (Hh-generating cell; black circle) are 
coplated with cells stably transfected with Gli-reporter and LacZ.  
In a cotransfection assay, a Shh expression construct is 
cotransfected with Gli-luciferase reporter and CMV promotor 
driven LacZ control into a Hh-responsive cell (shaded circle).  (B) 
and (C), Luciferase activity normalized to ß-galactosidase activity 
in response to control vector (EGFP) and Shh expression in 
coplating (B) and cotransfection assays (C).   
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region are preventing Shh from interacting with HSPGs. Thus, these amino 
terminal recombinant Shh-EGFP fusion constructs may not be trafficked 
effectively resulting in diminished signaling.  
The fusion constructs were also screened in transfected cells for the ability 
to undergo autoprocessing. NIH3T3 cells were transiently transfected with one of 
the Shh-EGFP constructs for 24 hours and then lysed. The whole cell lysate was 
co-immunoprecipitated with a monoclonal α-GFP antibody, separated on a 
polyacrylamide gel, and then transferred, and probed with a polyclonal α-GFP 
antibody. The fully processed form of Shh-FL is 45 kD, while the unprocessed 
precursor protein is 80 kD. Unlike the other Shh-FL constructs generated, 
ShhA193-EGFP was completely processed, showing a band at only 45 kD. In 
contrast, ShhR69-EGFP was only partly processed. Thus, the ShhA193-EGFP 
undergoes correct biogenesis, processing, receptor binding, secretion, and 
reception (Figure 22). We used ShhA193-EGFP for our future studies and also 
created Shh-EGFP constructs lacking a palmitoyl adduct (Figure A11), a 
cholesterol adduct, and an unmodified recombinant form of Shh. As we were 
interested in generating a Shh-EGFP zebrafish model, these mutational studies 
were not pursued further.   
 
Generation and identification of transgenic zebrafish   
Based on the assays described earlier, ShhA193-EGFP is fully processed 
and signals efficiently. To confirm its signaling capacity in vivo, ShhA193-EGFP 
capped mRNA was injected into a one cell stage of an olig2:DsRED zebrafish 
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Figure 22.	   Evaluation of Shh-FL auto-
processing.  The processed amino-terminal Shh-
EGFP fusion product (Mr = 50 kD) can be 
visualized for both ShhR69-EGFP and ShhA193-
EGFP transfections. The presence of unprocessed 
ShhR69-EGFP precursor protein (Mr ~ 80 kD) 
indicates that insertion of GFP in this location 
reduces the autoprocessing efficiency.  The 
apparent size difference between ShhR69-EGFP 
and ShhA193-EGFP appears to result from a shift 
in electrophoretic mobility rather than a difference 
in molecular weight.   
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embryo. These transgenic lines express dsRED within the olig2 domain of the 
ventral neural tube in response to Hh signaling (Shin et al. 2003). We found that 
injected capped ShhA193-EGFP mRNA signals with equal potency as injected 
wild-type Shh mRNA and displays a phenotype similar to that of Shh 
overexpression; the olig2:dsRED domain is expanded in the spinal cord and 
ventral diencephalon along with a shortened tail and “u” shaped somites (Krauss 
et al. 1993) (Figure 23). Thus, ShhA193-EGFP signals efficiently in zebrafish.  
 We introduced EGFP after the corresponding alanine in zebrafish Shh 
(zShh) cDNA. zShh contains one less amino acid then murine Shh, so the 
construct used in transgenesis is zShhA192-EGFP. In generating our zebrafish 
lines, we used the Gal4-UAS system (Scheer and Campos-Ortega 1999) to drive 
tissue specific expression of the zShh-FL constructs as we anticipate that 
embryonic malformations produced by zShhA193-EGFP, may hinder the 
production of transgenic lines. The driver line was generated to express Gal4 
under the power of regulatory sequences that control zShh temporal and spatial 
expression within the floor plate and notochord (Muller et al. 1999) (Figure 24). 
Effector lines were engineered to express zShh-FL fusion genes. Similar studies 
using GFP labeled Hh and the Gal4-UAS system have been performed 
successfully in Drosophila wing disc (Torroja et al. 2004).  
 The Gal4-UAS system uses two different kinds of lines, an activator and 
an effector line. In the activator line Gal4, a yeast regulatory protein that binds 
specific DNA motifs, namely Upstream Activating Sequences (UAS), activates  
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Figure 23.	   ShhA193-EGFP signaling in zebrafish. 
(A) and (B), olig2:dsRED expression within the 
ventral diencephalon (arrowhead)  and ventral spinal 
cord (arrow) in a transgenic zebrafish embryo, 
revealed by fluorescence imaging (A) and in situ 
hybridization (B). (C) and (D), Injection of mouse 
pCS2+ShhNHA193-EGFP capped mRNA at one-cell 
stage expands the expression domain of olig2:dsRED 
in the ventral diencephalon and spinal cord, and 
produces head and trunk malformation.  Note that the 
ventral diencephalon is misshaped, the chevron 
contour of the somites are lost, and the tail is 
shortened (C). 
	  
 	  
 84	  
transcription of a gene to which it is fused. The effector gene is silent unless 
crossed to the activator line (Fischer et al. 1988; Sadowski et al. 1988). We will 
be using Gal4-VP16 in our studies. Gal4 is fused to a portion of the herpes 
simplex virus protein VP16 resulting in a more potent transcriptional activator 
than Gal4 alone (Sadowski et al. 1988). The driver line we generated expresses 
Gal4 under the control of zShh regulatory sequences that have been 
characterized by Uwe Strähle, and control notochord and floor plate expression. 
These enhancers direct expression in both mouse and zebrafish indicating that 
regulation in these tissues is conserved (Muller et al. 1999). The effector lines 
express UAS linked to a zShh-FL fusion construct. Crossing the driver line with 
the effector line will produce embryos that temporally regulate expression of 
zShh-FL within the notochord and floor plate (Figure 24).  
As a method of transgenesis, we are using the Sleeping Beauty (SB) 
transposon system (Hermanson et al. 2004) that unlike plasmid injection reduces 
the possibility of high molecular weight extrachromosomal concatemer formation 
(Udvadia and Linney 2003), allows for higher germline transmission, better 
chromosomal integration, and more stable expression in zebrafish (Davidson et 
al. 2003; Hackett et al. 2005). The SB transposon system consists of a 
transposon vector with inverted repeat/direct repeat (IR/DR) regions flanking the 
gene of interest and a transposase that recognizes the ends of the IR/DR site.  
The transposase is used to excise the transposon from the vector and insert it 
into a 
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Figure 24.	   Schematic of method to generate transgenic zebrafish. (A) 
pT2 transposon contains a multicloning site (MCS), tissue specific γ-crystallin 
promoter linked to GFP sequences and flanking IR/DR transposon 
sequences.  For the driver construct, Shh regulatory, promoter, Gal4VP16 
and polyadenylation sequences are subcloned into pT2/ γ-Cry GM2 MCS.  
For the effector transposons, UAS and zShhNHEGFP sequences are 
subcloned into pT2/ γ-Cry GM2 MCS. (B) The γ-crystallin promoter linked to 
GFP sequences allows founder fish to be identified by GFP-positive lenses at 
2 dpf. (C) Shown are the intronic enhancer sequences used in creation of 
pT2-Gal4VP16-arB/C. 
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DNA site in the chromosome with TA base pairs. This is a highly coordinated 
event; the excision step is immediately followed by an integration step (Hackett et 
al. 2005) resulting in incorporation of a single cassette instead of multicopy 
concatemers.  
 The transgenes were cloned into pT2/γCry-GM2 vector (Davidson et al. 
2003) and 20pg of the DNA construct was injected into the cell of a 1 cell stage 
wild-type embryo followed immediately by injecting 200pg capped RNA encoding 
SB10 transposase into the yolk (Inbal et al. 2006). Injected embryos were raised 
to adulthood and crossed with wild-type fish. Founder lines were identified by 
GFP-positive lenses of their progeny at 2 dpf. Embryos with GFP positive lenses 
were used to generate transgenic lines. We generated eight different 
heterozygous lines and one homozygous Tg[UAS-zShhA192-EGFP] line which 
expresses fully modified zShh (Shha). We also generated two driver lines 
(Tg[ArB/C-Shh:Gal4-VP16]). 
 To determine activity of the distinct Tg[UAS-zShh-EGFP] effector lines, we 
used a transgenic line of zebrafish (Tg[gsc:Gal4-VP16]vu160) with Gal4 expression 
driven by Goosecoid regulatory sequences. In this line, Gal4 is transiently 
expressed in the hatching gland, prechordal plate mesoderm, and notochord 
during the first 24 hours of development (Inbal et al. 2006). From this screen, we 
isolated a line (Tg[UAS-zShh-EGFP]3913) that had the strongest EGFP 
expression as determined by live embryo imaging and immunohistochemistry. 
Comparing these results with expression patterns from Tg[gsc:Gal4-VP16]vu160-
/Tg[UAS-EGFP]vu157 (Inbal et al. 2006) progeny, suggested that zShh-EGFP  
 	  
 87	  
  
Figure 25.	   Characterization of zShh-EGFP expression in 
zebrafish. (A-E) Progeny from driver line Tg[gsc:Gal4-VP16] 
and effector line Tg[UAS-zShh-EGFP]. (A & B) zShh-EGFP 
expression at 24hpf is seen in the notochord and hatching 
gland. (C&D) Flatmounted embryos at 3s, immunostained with 
anti-GFP and visualized using Cy2 conjugated secondary 
antibody shows zShh-EGFP expression in the hatching gland 
(C) and in the notochord as well as some cell diameter away 
(D). (E) Live embryo imaged at 3s showing zShh-EGFP 
expression in the notochord and in surrounding tissue. (F) 
gsc:Gal4-VP16 embryo injected with UAS-zShh-EGFP and 
capped transposase mRNA shows zShh-EGFP expression in 
the notochord and surrounding mesoderm. 
 	  
 88	  
  
Figure 26.	  Visualization of EGFP or zShh-EGFP in 
the notochord and floor plate of a zebrafish 
embryo. (A) Progeny from driver line Tg[gsc:Gal4-
VP16] and effector line Tg[UAS-EGFP].  (B) Progeny 
from driver line Tg[gsc:Gal4] and effector line 
Tg[UAS-zShh-EGFP].  (A & B) Flat mounted embryos 
at 3s immunostained with anti-GFP and visualized 
with Cy2 secondary antibody shows diffuse 
expression in the notochord only (A) while (B) shows 
more localized zShh-EGFP expression in the 
notochord as well outside the notochord. (C) Tg[UAS-
EGFP] embryo injected with pT2GM2-ArB/C-Shh-
Gal4-VP16 DNA and capped RNA encoding SB 10 
transposase.  Live embryo imaged at 1dpf showing 
expression in the floor plate (a) and notochord (b).  	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expression was specific to Shh (Figure 26). Preliminary results show zShh-EGFP 
protein outside the notochord, some cell diameters away from the source in both 
fixed and live embryos (Figure 25). We did not characterize these lines further, 
but it would be interesting to determine what role Shh may have in the zebrafish 
hatching gland. The ultimate utility of this approach, however, depends upon the 
ability to visualize Shh-FL diffusion from a source of localized expression (Figure 
26C). 
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3.4 Discussion and Future Directions 
 
We generated transgenic zebrafish effector lines (Tg[UAS-zShh-EGFP] and 
Tg[UAS-zShhC24S-EGFP]) and driver lines (Tg[arB/C-Shh:Gal4-VP16]) that 
specifically drive Shh expression in the notochord and floor plate and may be 
used in future studies. New lines will have to be generated as over time and after 
multiple generations these lines no longer express zShh-EGFP. We have frozen 
stocks of sperm for several effector and driver lines that can be used to restore 
these transgenic zebrafish via in vitro fertilization (Ransom and Zon 1999). The 
absent Shh-EGFP expression is most likely the effect of DNA methylation and 
transcriptional silencing. Due to the CpG-rich tandem repeat, 14xUAS is also 
susceptible to methylation in vivo; in vertebrates these repeats are often targets 
of methylation (Giniger et al. 1985; Giniger and Ptashne 1988). By isolating 
tissue specific drivers that regulate GFP expression through a multicopy UAS, 
Goll et al. demonstrated that over succeeding generations, GFP expression 
diminished or was completely repressed. This transcriptional repression is a 
result of methylation of the multicopy UAS.  In addition, to in vitro fertilization 
using frozen sperm, silenced transgenes may be reactivated by augmenting 
Gal4-VP16 levels or by using DNA methyltransferase-1 mutant zebrafish lines 
(Goll et al. 2009). Nonetheless, future directions are described below and then 
more thoroughly in Chapter IV.  
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Characterization of transgenic zebrafish  
All independent lines generated would be characterized to determine 
which driver and effector lines are most appropriate to measure zShh-EGFP 
diffusion by ensuring that: 1. that strong zShh-EGFP expression is driven in the 
floor plate and 2. expression is exclusively in the floor plate and not in the ventral 
neural tube. This will allow for proper measurement of zShh-EGFP as a diffusible 
ligand. Tg[ArB/C-Shh:Gal4-VP16] embryos as well as the progeny from 
Tg[ArB/C-Shh:Gal4-VP16] and Tg[UAS-zShh-EGFP] or Tg[UAS-zShhC24SEGFP] 
crosses will be analyzed using immunohistochemistry, in situ hybridization, and 
live imaging at different developmental stages beginning at initial EGFP 
expression. Embryos from lines displaying the strongest EGFP expression using 
epifluoresence microscopy will be analyzed further. EGFP immunohistochemistry 
will be performed simultaneously to detect EGFP levels that may be too weak to 
be otherwise observed. Using riboprobes Gal4-VP16, Shh, Ptc, and EGFP 
(Thisse et al. 1993) whole mount in situ hybridization will be performed and then 
transverse sections of the spinal cord will be collected to determine Gal4-VP16 
mRNA expression profile (Inbal et al. 2006) in the neural tube and notochord 
(Park and Appel 2003) allowing us to demonstrate if EGFP presence is limited to 
the floor plate. By comparing Gal4-VP16 mRNA expression with EGFP protein 
expression, we will illustrate if in fact Shh protein is being secreted. We expect an 
overlap between Gal4-VP16 mRNA and EGFP protein expression, but that 
EGFP protein will also be present some distance away from the floor plate. 
Observing an overlap between shh mRNA and egfp mRNA will confirm that 
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EGFP can be used as a monitor of Shh presence. In addition, Ptc mRNA will be 
used as a read out for Hedgehog pathway activation (Chen and Struhl 1996; 
Briscoe et al. 2001). We expect there to be an expansion of the Ptc domain in 
Tg[ArB/C-Shh:Gal4-VP16]/Tg[UAS-zShh-EGFP] embryos due to Shh over 
expression. Using genomic DNA from adult zebrafish, all independent lines will 
also be characterized for transgene copy number by Southern blot analysis to 
ensure accurate comparisons between Tg[UAS-zShh-EGFP] and Tg[UAS-
zShhC24S-EGFP] lines. We plan to start our analysis at the tailbud stage as 
endogenous Shh is already expressed (Strahle and Blader 1994; Ekker et al. 
1995) and neural tube formation is beginning.  
 
Measuring the extent of Shh-EGFP ligand distribution in the ventral neural 
tube  
 
Live embryo and time lapse confocal imaging will be used to visualize the 
effects of the palmitoyl adduct on Shh gradient and long range signaling by 
comparing zShh-EGFP positive embryos with zShhC24S-EGFP ones while 
measuring the amount of EGFP expression away from the source of signal, the 
floor plate. Two live imaging experiments will be performed, one that will highlight 
the side of the embryo while the other will show a transverse section of the 
developing spinal cord. mRNA injections of membrane red fluorescent protein will 
aid in determining zShh-EGFP localization (Yin and Solnica-Krezel 2007). For 
the first experiment, time-lapse recordings will be collected every 5-10 minutes 
with focus on the midline of a dechorionated embryo oriented with dorsal to the 
top and anterior to the left to observe the floor plate and neural tube during and 
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after neural tube closure. Embryos will be mounted in 0.8% low melting point 
agarose in embryo media using glass bottom 35mm Petri dishes and imaged 
with Zeiss Axiovert 200 spinning disk confocal microscope or the LSM 510 
inverted confocal microscope. Images will be captured using a 40 and 60 times 
oil immersion lenses and analyzed with Improvision Openlab software (Kirby et 
al. 2006; Yin and Solnica-Krezel 2007). In the second experiment, we will 
examine the neural tube in the transverse plane through the trunk at the level of 
the hindbrain primordium during and after the end of neuralation in order to 
measure the extent of zShh-EGFP versus zShhC24S-EGFP trafficking during 
neural tube patterning. Embryos will be transferred to 0.2% agarose in embryo 
media and mounted in 3% methylcellulose on a coverslip enclosed by vacuum 
grease (Crump et al. 2004) and data will be analyzed as described above. EGFP 
immunohistochemistry will be performed simultaneously to detect EGFP levels 
that may be too weak to be otherwise observed. This will provide an alternate 
way to measure zShh-EGFP distribution in the ventral neural tube.  
 
Measuring Shh signaling and patterning  
Data from the trafficking studies proposed above will be compared to 
antibody staining for expression markers of graded signaling and the distance of 
these expression domains from the floor plate will be measured. We will compare 
EGFP and Ptc antibody staining patterns with neural tube markers to correlate 
Shh graded signaling with graded distribution and patterning in the ventral neural 
tube. Ptc will be used as a read out for Shh pathway activation and zShh-EGFP 
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antibody staining pattern to evaluate extent of Shh diffusion. As a read out for 
proper signaling, we will use induction of ventral neural tube antibody markers 
Axial (zebrafish homologue of HNF3β and a marker for lateral and medial floor 
plate), Nkx2.2, a lateral floor plate and ventral interneuron 3 marker (Odenthal et 
al. 2000; Park et al. 2004; Schafer et al. 2005) Isl1, a motor neuron marker, 
suppression of Pax7, and distance of the expression domains from the floor plate 
(Jessell 2000). In zebrafish, shh is expressed in the medial and lateral floor plate 
while twhh (tiggy-winkle hedgehog, a shh related gene) is restricted to the medial 
floor plate (Ekker et al. 1995; Lewis and Eisen 2001; Park et al. 2004). Though 
Shh is needed for motor neuron induction, Twhh can compensate for 
motorneuron development in the absence of Shh. To avoid the effects of Twhh 
on our analysis of Shh, we will use antisense morpholino oligonucleotides to 
suppress Twhh expression (Lewis and Eisen 2001). In addition to the lines and 
crosses described earlier, we will use progeny from the driver line and Tg[UAS-
EGFP] described earlier as a control to illustrate potential anomalies of zShh-
EGFP trafficking due to linkage of EGFP. Note that zShh-EGFP positive embryos 
will display a Shh overexpression phenotype so we expect to observe a decrease 
in ventralizing phenotype in zShhC24S-EGFP positive embryos. 
We hypothesize that zShhC24S-EGFP positive embryos will have an 
increase in Shh propagation, thus a broader range of EGFP expression, but will 
decrease in ventral neural tube progenitor domains and a decrease in Ptc protein 
levels, confirming that the palmitoyl adduct enhances cellular reception and 
potency. From in vitro studies described in Chapter II, the palmitoyl adduct also 
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promotes internalization, indicating that it may have an additional role in 
trafficking Shh, for example, to the primary cilium, to initiate a signaling event. 
Recently, Shh has been found to interact with several accessory proteins in Shh 
signal regulation. It would be interesting to determine what role, if any, the 
palmitoyl adduct may have in promoting association with these other binding 
partners (Beachy et al. 2010). Additional future directions and other possible 
uses for these transgenic lines are discussed further in Chapter IV. Alternate 
approaches to the methods described above are detailed in Appendix A2.2. 
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CHAPTER IV 
 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
4.1 Summary 
 
Sonic hedgehog (Shh) signaling is an important mechanism for regulating 
cell growth during embryonic development, tissue homeostasis and 
tumorigenesis. In responding tissues, concentration and duration of cellular 
contact to secreted Shh protein are essential for tissue patterning. Shh ligand is 
covalently modified by two lipid moieties, cholesterol and palmitate, and their 
hydrophobic properties govern the cellular release and formation of soluble 
multimeric Shh complexes. My studies were designed to gain insight into the 
influences of the lipid moieties on cellular reception and signal response. To 
implement these studies, recombinant forms of Shh ligand that were either fully 
lipidated or had one or both lipid adducts eliminated, were analyzed in NIH3T3 
mouse embryonic fibroblasts. Quantitative measurements of recombinant Shh 
protein concentration, cellular localization, and signaling potency were integrated 
to determine the contributions of each lipid adduct on ligand cellular localization 
and signaling potency. Our studies demonstrate that lipid modification is required 
for cell reception, that either adduct is sufficient to confer cellular association, that 
the cholesterol adduct anchors ligand to the plasma membrane and that the 
palmitate adduct augments ligand internalization. We further show that, 
independent of the formation of multimeric Shh protein complexes, signaling 
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potency correlates directly with cellular concentration of Shh ligand independent 
of the formation of multimeric Shh protein complexes. Our findings demonstrate 
that lipid modification of Shh determines its cell concentration and potency, 
revealing complementary functions of hydrophobic modification in morphogen 
signaling by attenuating cellular release and augmenting reception of Shh protein 
in target tissues. 
Additionally, to explore these questions in vivo, we generated a 
visualizable form of the Shh ligand for expression and imaging in zebrafish 
embryos. This fluorescent form of Shh retains autoprocessing, is lipid modified, 
binds Ptc, and signals effectively, both upon transfection of ligand and when Shh 
protein is exogenously provided to responsive cells transfected with Gli reporter. 
Employing this visualizable form of Shh (ShhA192-EGFP) and using the binary 
Gal4-UAS system to drive tissue specific Shh expression, transgenic lines of 
zebrafish were created containing genomic sequences that regulate Shh-EGFP 
temporal and spatial expression within the notochord and floor plate. We also 
generated transgenic lines of mutant forms of Hh protein lacking a palmitoyl or 
cholesteryl adduct (ShhC24S-EGFP and ShhN-EGFP respectively). The optical 
clarity of zebrafish embryos allows for real time visualization of individual cell 
behaviors. These tools will help illuminate the role of Shh lipid adducts on tissue 
patterning, ligand distribution, and signal potency. Furthermore, it would be 
interesting to explore the role of palmitate and cholesterol moieties on the ability 
of Hh to interact with other binding partners, such as membrane associated 
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proteins Gas 1, BOC, CDO, and HSPGs or even with organelles like primary 
cilia.  
 
4.2 A Discussion of Two Opposing Models 
 
Diametrically opposing views of the lipid modifications and Hedgehog 
signaling 
 
In direct contrast to our findings, Ohlig et al. recently presented an 
intriguing model whereby the lipid modifications must be cleaved in order to shed 
Shh ligand from producing cells and render the multimeric conformation 
competent for signaling (Ohlig et al. 2011). This article builds upon previous work 
from the same group suggesting that a disintegrin and metalloprotease (ADAM) 
mediates shedding of Shh from its lipid adducts resulting in a soluble and 
secreted form of Shh protein (Dierker et al. 2009). According to the model, the 
palmitoyl adduct is required for ADAM-mediated removal of 8-10 amino acids 
from the amino terminus of the Shh ligand. In the absence of proteolysis, these 
amino terminal sequences occupy the Ptc binding site of adjacent Shh ligands in 
the multimer and inhibit signaling (Figure 27).  
The foundation of the model is based upon the authors’ observations that 
removal of the palmitate (ShhC25S) allowed for Shh multimerization and release 
in the absence of ADAM-mediated proteolysis of amino-terminal Shh sequences. 
Furthermore they found that the ShhC25S multimer demonstrated markedly 
reduced signaling in C3H10T1/2 osteoblast precursor cells.  To test the model,  
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Figure 27.	   The palmitoyl adduct is required for 
multimeric Shh shedding. The palmitoyl adduct is 
needed for ADAM-mediated removal of amino acid 
residues from the amino terminus of Shh ligand. In the 
absence of proteolysis, these amino terminal 
sequences occupy the Ptc binding site and inhibit Shh 
signaling.   
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the authors found that monomeric ligand that had not undergone ADAM-
mediated proteolysis (ShhNC25S and ShhN) signaled with full potency in a chick 
chondrocyte differentiation assay. They hypothesize that since these mutant 
forms are only monomeric, the palmitoyl adduct is no longer needed to mediate 
proteolysis and unblock the Shh Ptc binding site required for signaling.  Thus, 
they concluded that the multimeric form of Shh is not required for signaling per 
se, but that there was a strict requirement for removal of amino terminal 
sequences in order for multimeric Shh to signal.  
This model is diametrically opposed to our findings that the lipid adducts 
are critical for cellular response to Shh ligand (see Chapter II and Figure 28). The 
details of our experiments and those conducted by Ohlig et al. deserve closer 
inspection. Our studies employed quantitative methods for determining both the 
exact concentrations of Shh protein that cells were exposed to, and for 
measuring the degree of signal response. Additionally, we employed highly 
responsive cells, a Gli-luciferase reporter, and carefully measured a dose 
response for each form of recombinant Shh. In the studies performed by Ohlig et 
al., recombinant Shh quantity for the C3H10T1/2 cell signaling assays was 
estimated by western blot analysis. This qualitative approach is quite different 
from our quantification of Shh ligand by ELISA.  As such, very different 
concentrations of recombinant Shh may have been compared for signaling 
assays in the Ohlig et al. studies. For example, we determined by ELISA that 
removal of lipid adducts resulted in either a 2.5-fold or a 10-fold increase in 
secreted ligand for ShhC25S and ShhNC25S, respectively. Additionally,  
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A.           B.           C.       D.
cholesterol
palmitate
Shh     Shh -palmitate  Shh -cholesterol             Shh -both lipid adducts  
Figure 28.	   The Shh lipid adducts are required for cellular association and 
consequently signaling. (A) Both cholesterol and palmitate confer the highest 
degree of surface association. (B) Cholesterol enhances Shh cell surface 
association. (C) Palmitate augments Shh internalization. (D) In the absence of 
either lipid adduct, Shh is not readily able to associate with the cell resulting in 
significantly diminished Shh signaling capability.  See Chapter II for more 
detailed discussion.   
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C3H10T1/2 osteoblast precursor cells are far less responsive than NIH3T3 
mouse embryonic fibroblasts and employ alkaline phosphatase production to 
indicate Shh signaling. Alkaline phosphatase production reflects C3H10T1/2 cell 
differentiation in response to Shh signaling, and represents a qualitative 
threshold response. Thus, important differences in signaling potency may not be 
apparent when using C3H10T1/2 cells. Furthermore, all of the signaling assays 
in the Ohlig et al. study employed a single dose of recombinant Shh ligand 
instead of a dose response curve. Finally, the most crucial signaling assay of 
monomeric Shh (ShhNC25S) to support the model for ADAM-mediated 
processing was performed using a chick chondrocyte differentiation assay. This 
assay utilizes a biphasic readout of signaling (presence or absence of collagenX) 
and is thus qualitative. Furthermore, in this particular instance the chondrocytes 
were incubated with an unknown amount of recombinant ShhNC25S protein (a 
1:1 ratio of conditioned medium to DMEM). These differences in methodology 
and data interpretation are critical. If we had used threshold or biphasic signaling 
responses as readouts for our studies, we may have concluded that all 
recombinant forms of Shh signal with equal potency.  Yet, by generating a dose 
response curve with a linear signaling readout and precisely quantifying 
concentrations of Shh protein, we were able to tease out important difference 
that would have otherwise been missed. That being said, in addition to NIH3T3 
cells, we also employed C3H10T1/2 cells in our studies and the signaling results 
with quantified amounts of recombinant Shh protein mirrored the results of our 
luciferase based assays in NIH3T3 cells. We found that ShhNC25S did not signal 
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nearly as well as Shh and in fact only minimal signaling was detected after 
subjecting C3H10T1/2 cells to ShhNC25S protein for over 100 hours (Figure A9). 
According to the model proposed by Ohlig et al., the multimeric form of 
ShhC25S fails to signal because the Ptc binding site of one Shh ligand is 
occupied by amino terminal sequences of an adjacent Shh ligand. If so, signal 
response to ShhC25S should remain the same regardless of the amount of 
recombinant ShhC25S protein added to cells. They did not perform this 
experiment which would have effectively tested their model. Had I reviewed the 
manuscript, I would have asked for this critical experiment.  
 
4.3 Outstanding Questions 
 
David versus Goliath: Potency of the elusive Shh multimeric complex 
versus the enigmatic Shh monomer 
 
The multimeric form of Shh is not required for Hedgehog signaling, but is 
thought to be more potent than Shh monomer (Chen et al. 2004; Goetz et al. 
2006). Shh multimeric complexes may be the primary biologically relevant form 
of Shh in vivo and could be involved in trafficking and packaging Shh for delivery 
to the cellular membrane (Steinhauer and Treisman 2009). Our data indicate that 
fully lipidated Shh ligand should signal with equal potency regardless of whether 
it is presented to receiving cells in a multimeric or monomeric conformation; it is 
the number of Shh ligands delivered to the cell that is imperative. In support, we 
have found that the signaling potency of Shh conditioned medium from 
transiently transfected cells does not appear to be concentrated in the 10-20% of 
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Shh protein that is in a multimeric conformation. Moreover, several studies (Zeng 
et al. 2001; Chen et al. 2004; Goetz et al. 2006) including ours established that 
both lipid adducts are required for multimerization and that neither cholesterol nor 
palmitate is required for Hh binding to Ptc (Fuse et al. 1999; Williams et al. 1999). 
Further complicating the notion of multimerization is a study that differentiated 
between medium (66-669 kDa) and large size (>669 kDa) multimers and 
proposed that both lipid moieties are needed for large multimers, but that either 
lipid adduct is sufficient for the formation of mid-sized multimers. Active Shh 
signaling, however, is limited to either large multimeric complexes or mid-sized 
multimers created from the palmitoyl adduct alone (Feng et al. 2004). Our 
preliminary data suggest that monomer and multimer have equal potency, but 
this has not been conclusively illustrated  (Figures 16, 19, A1 and A2; Appendix 
A.1.1). I propose the following to resolve the discrepancies between previous 
works and to confirm that Shh multimerization does not affect signal potency.  
 We, and other groups (Zeng et al. 2001; Goetz et al. 2006), have shown 
that the majority of Shh isolated from conditioned medium from stably transfected 
Shh cell lines (e.g. HEK293 cells containing an ecdysone-inducible Shh 
expression construct (Cooper et al. 1998)) is in the multimeric fraction. 
Generation of stably-transfected cells for all of the recombinant forms of Shh 
analyzed in this manuscript would be required to enhance the multimer to 
monomer ratio and rigorously test for the presence or absence of multimeric Shh 
following removal of one or both of the lipid moieties as well as to compare the 
signaling potency of multimeric and monomeric Shh. Following size exclusion 
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chromatography, elusion fractions would be used in Gli-reporter based 
chemiluminescent signaling assays. Monoclonal anti-Shh 5E1 antibody 
purification columns may also be employed to concentrate Shh protein fractions 
(Ericson et al. 1996; Feng et al. 2004). All the recombinant forms of Shh 
previously discussed bind to 5E1 conjugated protein G beads with equal affinity 
(Figure A8). Additionally, Shh responsiveness in Light 2 cells (NIH3T3 embryonic 
fibroblasts stably transfected with Gli responsive Firefly luciferase and 
constitutive Renilla luciferase) can be enhanced by altering culture conditions; 
DMEM supplemented with Ham’s F12 Nutrient Mixture (Invitrogen) resulted in 
four times greater signaling when compared to standard culture conditions 
(Figure A7). This increase in sensitivity may allow low levels of signaling to be 
more detectable and may uncover otherwise unapparent differences or confirm 
similarities between multimeric and monomeric signaling capacity.  
 
Further examining Shh multimeric complexes and the role of 
Dispatched on multimer secretion  
  
 Hedgehog multimerization studies have only been analyzed using size 
exclusion gel filtration chromatography on Shh secreted into culture medium from 
either transfected cells or posterior limb buds (Zeng et al. 2001; Chen et al. 2004; 
Goetz et al. 2006). Speculation deems that Shh multimerization occurs on the 
cell surface (Zeng et al. 2001), but we do not know whether Shh is secreted as 
multimer via Dispatched1 (Disp1 or mDispA), or whether it is secreted as a 
monomer, multimerizes on the cell surface, and is then released by Disp1. Disp1 
mediates secretion of lipid modified Shh and also plays a role in long range 
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signaling (Burke et al. 1999; Caspary et al. 2002; Kawakami et al. 2002; Ma et al. 
2002). Though, Disp1 is not required to generate a Shh response, the range of 
Hh distribution from its site of synthesis is decreased in Disp1-/- tissue even if 
Shh is correctly produced and secreted using Disp1 expressing cells. Therefore, 
Disp1 is not only important in expressing cells, but may be involved in spreading 
and distributing Shh. This role for Disp1 in mediating Shh transport supports the 
notion that it may enhance Shh multimerization that inadvertently may augment 
long range signaling (Etheridge et al. 2010). It would be exciting to observe 
multimerization in action on the surface of live cells and to investigate further the 
mechanistic roles of Disp1.  
 Using flow cytometry in combination with fluorescence resonance energy 
transfer (FRET) may allow detection of Shh multimerization on the surface of live 
cells. NIH3T3 cells co-transfected with three separate Shh fluorescent 
constructs, conjugated to cyan fluorescently protein (CFP), yellow fluorescent 
protein (YFP) or mRFP (monomeric red fluorescent protein) would be subject to 
2-step FRET analysis using flow cytometry. Favorable geometric orientation and 
close proximity of the proteins and fluorophores are necessary for favorable 
FRET. These fluorophores share significant spectral overlap and due to their 
small size tend not to greatly alter the geometry of the protein they are linked to 
or the interaction between the chromophores themselves, making them good 
contenders for FRET. The efficiency of energy transfer from donor to acceptor 
chromophore is based on the Förster equation and is inversely proportional to 
the sixth power of the distance separating the two chromophores. Thus, even a 
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slight decrease in the distance between fluorophores results in substantial 
decrease in FRET (Dye 2005). If Shh undergoes multimerization, light energy 
that excites Shh-CFP fusion protein (donor) would be transferred to Shh-YFP 
(acceptor) indicating that the two proteins interacted. Trimerization would take 
this a step further resulting in mRFP fluorescence; energy transferred to Shh-
YFP would then also be transferred to Shh-mRFP. Due to excitation and 
emission overlaps, CFP-YFP FRET and YFP-mRFP FRET are more efficient 
than direct CFP-mRFP FRET. In addition, measuring CFP and CFP-YFP FRET 
quenching would be another indicator of 2-step FRET (Dye 2005; He et al. 2005). 
ShhC25S or ShhN fluorescently labeled constructs would serve as controls as 
they associate with the cell surface, but do not multimerize. Fluorescence 
microscopy would further validate the flow cytometry results as well as provide 
additional cellular localization data (Banning et al. 2010). Furthermore, to test the 
role of Disp on Shh surface multimerization and secretion, the experiments 
described above could be repeated using transfected mDispA -/- mouse 
embryonic fibroblasts (MEF) (Ma et al. 2002).  
 
A model for lipid adducts in Shh signal regulation 
 Our studies demonstrate that, though both the Shh palmitate and 
cholesterol moieties can each confer cellular association, it is the cholesterol 
adduct that anchors ligand to the surface of the plasma membrane and the 
palmitate adduct that augments ligand internalization. Assume: 1. We are only 
considering what happens to Shh once it reaches the cell, 2. Shh ligand 
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internalization implies that Shh is being degraded and thus has just partaken in a 
signaling event and 3. Shh signaling is principally mediated via primary cilia. 
Based on these assumptions we propose the following model:  The cholesterol 
adduct anchors Shh to the cellular membrane, holding Shh at the surface until it 
is required for signaling. The palmitoyl adduct is involved in trafficking Shh to the 
cilium and participating in a signaling event prior to ligand internalization. In the 
absence of cholesterol forcefully tethering Shh to the membrane, Shh is 
vigorously shuttled to the cilium to undergo signaling and is then degraded. In the 
presence of cholesterol alone, fewer Shh ligands traffic to the cilium resulting in 
less Smo association with the cilium, and diminished signal response. We further 
propose that other Shh binding partners that positively regulate the pathway may 
be involved in trafficking Shh to the cilium to generate a Shh signaling event. We 
suggest that the palmitoyl adduct may enhance Shh interaction with these other 
binding partners and could facilitate binding to Shh (Figure 29). In the following 
sections we propose methods and provide additional background required to test 
this hypothesis.  
 
Shh lipid adducts and the primary cilium 
 To initially test our hypothesis and determine the role of the Hh lipid 
adducts on trafficking, we would transfect mouse embryonic fibroblasts, such as 
NIH3T3 cells, with the fluorescent labeled (FL) Shh constructs we generated 
(ShhA193-FL, ShhNA193-FL, and ShhC25SA193-FL). Assuming that we are 
able to visualize Shh-FL on cilium type structures, we would then confirm that  
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Figure 29.	   A model for lipid adducts in Shh signal regulation. (A) In the 
absence of Shh ligand, Ptc is concentrated in the primary cilium.  Inactivation of 
Ptc by Hh enables Smo to accumulate in ciliary membranes. (B) Shown is a 
possible model based on our studies, suggesting that the cholesterol adduct 
anchors Shh to the cellular membrane; holding Shh at the surface until it is 
required for signaling.  On the other hand, the palmitoyl adduct is involved in 
trafficking Shh to the cilium resulting in a signal response before the ligand is 
internalized for degradation.  In the absence of cholesterol forcefully tethering 
Shh to the membrane, Shh is rapidly shuttled to the cilium to undergo signaling 
and is then degraded; not only is the concentration of Shh in the cilium greater, 
but the rate at which it is trafficked increases.  In the presence of cholesterol 
alone, fewer Shh ligands traffic to the cilium at a slower rate resulting in less Smo 
association with the cilium, and diminished signal response. 
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Shh is in fact present on cilium by using primary cilia specific markers Inversin 
and Pericentrin. Inversin marks primary cilia and is not involved in Hh signaling. 
Additionally, Pericentrin localizes around the basal body and is found at the base 
of primary cilia. Observing co-localization between Shh-FL and fluorescently 
labeled versions of these cilia specific markers would serve as a proof of 
principle (Rohatgi et al. 2007). Next, using fluorescence recovery after 
photobleaching (FRAP) (Reviewed in (Lippincott-Schwartz et al. 2003)), we will 
be able to selectively photobleach the primary cilium with a high-intensity laser 
and measure the rate of recovery occurring as Shh-FL returns to the previously 
bleached cilium. Fluorescence recovery would be a measure of Shh-FL 
trafficking to the cilium. Analysis of fluorescence recovery by quantifying the time 
of non-bleached Shh-FL to return to photobleached area would allow us to 
differentiate between the roles of the palmitate and cholesterol Shh adducts. We 
hypothesize that Shh lacking the palmitoyl moiety would require more time to 
reach and be less concentrated at the cilium, while Shh lacking the cholesterol 
adduct would be trafficked at a faster rate and have a higher concentration on the 
cilium than wild-type Shh. 
Another way to examine a Shh signaling event is to observe an increase 
of Smo localization to the primary cilia. In the absence of Hh ligand, Ptc is 
concentrated in cilia (Huangfu and Anderson 2005; Rohatgi et al. 2007) and acts 
catalytically to suppress the activity of Smoothened (Smo) (Taipale et al. 2002). 
Inactivation of Ptc by Hh binding removes Ptc from the cilium, enabling Smo to 
accumulate in ciliary membranes (Rohatgi et al. 2007; Milenkovic et al. 2009). 
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This accumulation is followed by a secondary process converting Smo to an 
active state (Rohatgi and Scott 2008; Rohatgi et al. 2009). We propose using 
Smo accumulation in the cilium as a readout for Shh signaling. We would also 
employ pharmacological reagents allowing us to differentiate between the 
various states of Smo and confirm that Smo is in fact in a signaling state and not 
just merely on the cilium (Rohatgi et al. 2009). NIH3T3 fibroblasts, transfected 
with fluorescently labeled Smo (Smo-FL) would be subject to real time 
fluorescent imaging upon the addition of unlabeled wild-type and mutant (ShhN 
and ShhC25S) Shh protein. We hypothesize that in the absence of the palmitoyl 
adduct, less Smo would localize to the cilia at a slower rate (fluorescence 
intensity may also be diminished suggesting less Smo on the cilium) while in the 
absence of the cholesteryl adduct, Smo would reach the cilium faster and be 
more concentrated in cilia. In zebrafish, primary cilia also play a role in Shh 
signal transduction (Huang and Schier 2009), thus these studies may be pursued 
further using our transgenic zebrafish models. We may be able to visually 
observe the spatial distribution of Shh and determine whether the palmitoyl 
adduct has a function in modulating signaling via the primary cilium.  
  
Shh lipid adducts in spatial and temporal gradients 
 In the neural tube, Shh is secreted from localized sources, specifically the 
notochord and floor plate, and patterns the ventral neural tube in both a 
concentration and temporal dependent manner (Roelink et al. 1995; Dessaud et 
al. 2007). The importance of Shh exposure as well as duration is also apparent in 
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the limb bud where Shh is involved in posterior digit formation (Harfe et al. 2004). 
Ex vivo experiments suggest that when neural plate explants are immersed for 
short periods of time in either high or low concentrations of Shh protein, they 
generate similar levels of Gli and transcriptional responses. Over time though, Gli 
expression decreases as Ptc is upregulated and cells desensitize to the 
continuous Shh signal. This leads to a conversion of Shh concentration to a 
specific period of Gli activity and more ventral target genes are expressed (Jeong 
and McMahon 2005; Stamataki et al. 2005; Dessaud et al. 2007). Changes in the 
concentration of or the duration of Shh exposure may have similar effects on 
transcription responses, as reducing either results in a decreases in intracellular 
Gli as cellular identity requires Gli activity to be maintained above a particular 
threshold (Reviewed in (Ribes and Briscoe 2009)). 
 Shh signaling data described in Chapter II were collected at a specific time 
point, and thus we were unable to determine the effect of lipid adducts on Shh 
signaling or localization over time. Preliminary data from experiments examining 
osteoblast differentiation in C3H101/2 cells (osteoblast differentiation requires a 
specific threshold of Shh signaling (Kinto et al. 1997)) did not demonstrate a 
novel role for Shh lipid adducts on temporal kinetics of signaling (Figure A9, 
Appendix 2.1 for further discussion of these results). Osteoblast differentiation, 
however, does not allow for a readout of graded Shh threshold responses. More 
precise measurements will be obtained by repeating this experiment and 
observing differentiation (by examining transcription expression profiles, Figure 
3) in chick neural plate explants incubated over time with quantified amounts of 
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Shh protein. Two possible experiments could be performed. In the first, neural 
plate explants will be subjected to the same concentration of Shh protein over 
different time intervals. If the palmitoyl adduct is involved in shuttling Shh to cilia, 
then Shh in the absence of the cholesterol adduct would impart a particular cell 
fate faster than wild-type Shh. On the other hand, in the absence of the palmitoyl 
adduct it would take longer to attain that same cellular fate. This potential 
difference between lipid adducts may be more evident by examining cell types 
that require more Shh to differentiate. In the second experiment, neural plate 
explants would be subjected to Shh protein for the same duration and then 
analyzed. If the palmitoyl moiety enhances Shh localization to the cilium, 
signaling may proceed at a faster rate. Therefore, over the same period of time, 
Shh lacking the cholesterol adduct may result in a lower threshold response or a 
more dorsal neuronal phenotype. While, in the absence of the palmitoyl moiety, 
higher threshold response would be achieved. As described above, tissue 
exposed to Shh protein for long periods of time eventually becomes sensitized 
and Shh ligand no longer influences differentiation (Dessaud et al. 2007). In the 
absence of Shh lipid adducts, the time for cells to reach this level of sensitization 
and differentiate could increase if palmitate enhances signaling and affects Shh 
potency.  
 
Shh binding partners and the Shh palmitoyl adduct  
 Additionally, we propose that other Shh binding partners that positively 
regulate the pathway may be involved in trafficking Shh to the cilium to generate 
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a Shh signaling event. We suggest that the palmitoyl adduct may enhance Shh 
interaction with these other binding partners and could facilitate binding to Shh. 
Accessory proteins, CDO, BOC and Gas1 directly bind Shh and either CDO/BOC 
or Gas1 in addition to Ptc are required for Shh mediated differentiation and 
proliferation. These additional binding partners, however, are not required for 
Shh to bind Ptc (Allen et al. 2011; Izzi et al. 2011). Ptc is thought to mediate Shh 
endocytosis (Incardona et al. 2000). Furthermore, we demonstrate that the Shh 
palmitoyl adduct enhances surface association and may also modulate Shh 
ligand internalization. Collectively, this suggests a role for the palmitoyl adduct in 
facilitating interactions with CDO, BOC, and Gas1. This interaction could occur 
after Shh binds Ptc and binding CDO/BOC could facilitate Shh concentration in 
the cilium. Megalin (Lrp2), another Shh binding protein, is involved in Shh 
endocytosis, which is inhibited by heparin (McCarthy et al. 2002), suggesting that 
Shh signaling may also be modulated by glypican heparin chains; once Shh is no 
longer required on the cell surface, Megalin, in the absence of heparin, 
internalizes excess Shh. The palmitoyl adduct may be involved in Shh binding to 
Megalin or in Shh endocytosis.  
 Preliminary observations using fluorescent microscopy show internalization 
and colocalization of ShhA193-ECFP with Ptc-EYFP in signal receiving cells 
(Figure A10, Appendix A2.1). This method and these studies may be used to 
answer questions regarding the role of the palmitoyl adduct in Shh interaction 
with Ptc, Megalin and other binding partners. In addition, fluorescent protein 
subcellular localization markers and antibody staining could be used to 
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characterize the cellular compartments in which Shh-FL and ShhC25S-FL are 
localized. Follow up experiments could include examination of protein localization 
within isolated membranes such as lipid rafts and organelles like primary cilia or 
cytonemes. The role of the Shh palmitoyl adduct in Hh interaction with other 
proteins may be further explored using standard methods to over-express or 
knock down gene function of Shh binding partners in transgenic zebrafish lines 
Tg[UAS-zShhC24S-EGFP] and Tg[UAS-zShh-EGFP] as previously described.  
  
In conclusion, the studies described in this thesis highlight the importance of the 
cholesteryl and palmitoyl adducts on Shh trafficking, localization, and signaling in 
vitro and provide an in vivo model for continued analysis.  
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APPENDIX 
 
A1.1 Isolation of multimeric and monomeric Shh fractions and their role in 
Hh signaling. 
 
The multimeric form of Shh is not required for Hedgehog signaling, but is 
thought to be more potent than Shh monomer (Chen et al. 2004; Goetz et al. 
2006). Our data suggests that monomer and multimer Shh may have equal 
potency, but more rigorous analysis is required. The technical issues we 
encountered and other supporting figures are described below and in figures A1 
and A2. See Chapter IV and figure A7 for alternate methods and further analysis.  
 Our data do not indicate that the signaling potency of Shh conditioned 
medium from transiently transfected cells resides in the multimeric fraction (which 
represents 10-20% of total Shh protein by either Superose 12 or Superose 6 
HPLC). Instead, our data are more consistent with multimer and monomer having 
roughly equivalent signaling potency. Low relative abundance of multimeric Shh 
has impeded rigorous testing of the contribution of multimerization on signaling 
potency.  
 We have analyzed Shh conditioned medium from transiently transfected 
cells on a Superose 12 column and found that the yield of multimeric Shh protein 
is lower than that of a Superose 6 column (Figure A1). Previous studies have 
been performed using Superose 12 or Superdex 200 that is better for low 
molecular weight separation HPLC columns (Zeng et al. 2001; Chen et al. 2004; 
Goetz et al. 2006). We also analyzed the effects of detergent concentration  
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Figure A1. HEK293T cells transiently transfected with Shh and 
fractionated on a size exclusion column. Conditioned medium from 
HEK293T cells transfected with recombinant Shh was concentrated (Amicon® 
Ultra-15 centrifugation filter; Millipore) and analyzed by HPLC (High 
Performance Liquid Chromatography) at 4°C using the Amersham 
Biosciences ÄKTA Purifier P-900 (GE Healthcare Life Sciences). Conditioned 
medium was fractionated using a Superose 12 10/300 GL column (GE 
Healthcare Life Sciences) equilibrated in PBS with either 0.1% or 0.01% NP-
40. The 0.5 mL elution fractions were collected and analyzed by ELISA. The 
column void volume is 7 mL.  Regardless of detergent concentration the 
percentage of multimeric Shh isolated with the Superose 12 column was 
approximately 11%. In contrast, the percentage of multimeric Shh isolated 
with the Superose 6 column was 22%. 
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and determined that the yield of multimeric Shh in the conditioned medium we 
have generated is not enhanced by detergent concentration used to equilibrate 
the Superose 12 column (0.0001-0.1% Nonidet P-40. We conclude that, as 
reported (Goetz et al. 2006) the ratio of multimer to monomer is low in transiently 
transfected cells.  
 Figure 19 contains the data from our best experiment and suggests that 
both forms of Shh protein signal with equal potency. Measurable Shh signaling 
(Gli reporter activity) was also detected using approximately 200 kDa mid-size 
multimers (0.5 mL elution volume fractions 10-12) (Figure A1 and data not 
shown), however due to low protein concentration in these fractions quantitative 
dose response analysis could not be performed. This is the only experiment, out 
of a total of 5 independent experiments, for which we achieved detectable 
signaling, albeit at 1/10 of maximum levels for unfractionated conditioned media. 
The two next best experiments, shown in Figure A2, illustrate the technical 
challenges we faced in purifying sufficient quantities of multimeric and 
monomeric Shh protein for signaling assays.  
 To perform the signaling assay illustrated in Figure 19, for example, 1.7 
liters of Shh-conditioned medium was concentrated for purification of multimeric 
and monomeric Shh protein by size exclusion chromatography. Shown in Figure 
A2 are the results of 2 other experiments to illustrate the technical limitations and 
important caveats. Shh-conditioned medium was concentrated to approximately 
18 nM as determined by ELISA and was not dialyzed prior to use in a signaling 
assay (Figure A2(A)). The signaling curve for the conditioned medium  
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Figure A2. Shh signaling assays using multimer and monomer 
fractions of Shh protein separated on a size exclusion column. 
Shown are two experiments comparing the signaling potency of 
concentrated conditioned medium (CM) from HEK293T cells 
transfected with recombinant Shh and the multimeric and 
monomeric fractions of Shh protein following purification with either 
a Superose 6 (A) or Superose 12 (B) column. Shh signaling was 
measured by chemiluminescence in triplicate wells of NIH3T3 cells 
transfected with Gli-reporter (8xGli-luciferase) and β-galactosidase. 
Shown are the averaged relative luciferase values for 2-fold 
dilutions of each Shh protein preparation with the starting dilution 
labeled for each tracing. (A) The Shh-conditioned medium was not 
dialyzed and the multimeric and monomeric Shh fractions were 
dialyzed in DMEM before the signaling assay. (B) All of the 
multimer, monomer, and CM preparations were dialyzed before the 
signaling assay. 
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demonstrates that serial dilution was required to eliminate the presence of an 
inhibitory substance in the concentrated medium and that the EC50 for this assay 
was ~0.8 nM. The Shh multimer and monomer fractions purified from a Superose 
6 column were then dialyzed and analyzed for signaling potency at 2-fold serial 
dilutions. The yield of monomer and multimer, however, appear to have been too 
low to obtain signaling competent Shh protein after serial dilution. Shh-
conditioned medium was concentrated to approximately 96 nM as determined by 
ELISA (Figure A2(B)). After dialysis, however, the concentration by ELISA was 
461 nM. ELISA readings of the HPLC fractions also differed before and after 
dialysis, but to a lesser extent, indicating that dialysis can affect the results of the 
ELISA assay for both fractionated and unfractionated conditioned medium. The 
signaling curve for this batch of concentrated conditioned medium revealed that 
serial dilution was still required to eliminate the presence of an inhibitory 
substance despite dialysis and that the EC50 for this assay was ~6.3 nM based 
on the ELISA reading after dialysis. The Shh multimer and monomer fractions 
purified from the Superose 12 column were dialyzed and analyzed for signaling 
potency at 2-fold serial dilutions (starting at 1 to 8 for the monomer and 1 to 3 for 
the multimer fractions) (Figure A2). Again, however, the yield of monomer and 
multimer appear to have been too low to adequately compare signaling potency. 
Based on the results of numerous experiments, it is clear that the low relative 
abundance of multimeric Shh in our conditioned medium and the accumulation of 
an inhibitory factor during concentration precluded rigorous testing of the 
signaling potency of multimeric versus monomeric Shh. See Chapter IV for 
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further discussion and future experimentation.  
 
A2.1 Additional discussion of figures 
 
Figure A3:  Shh signaling in the chick neural tube 
Though this experiment yielded no results, it offers an additional method 
to the zebrafish studies proposed in Chapter III. By simply electroporating Shh-
EGFP in to the chick neural tube, we were unable to differentiate between cells 
that were electroporated with Shh-EGFP and those that received it as a result of 
Shh trafficking (A3 A and B). We created a bicistronic vector, pCIG-Shh-EGFP-
IRES-dsRED, to differentiate between electroporated cells and cells that 
exogenously received Shh. Electroporated cells will express dsRed in the 
nucleus and EGFP, while cells receiving Shh-EGFP will only express EGFP. This 
provides a “localized” source of Shh. We would be able to measure the range of 
Shh-EGFP and ShhC25S-EGFP and correlate distribution with signaling by 
examining transcription factor expression profiles in the VNT.   
 
Figure A4, A5, and A6:  Shh(n-5) cellular distribution and signaling 
 Shh(n-5) has similar cellular localization to ShhC25S and ShhC25A, all of 
which lack the Shh palmitoyl adduct. Its EC50 is 0.09 pg/cell which is significantly 
higher than all the other recombinant Shh constructs used in this study. Thus, its 
inefficient signaling may be due to a conformational change that prevents it from 
interacting with other Shh regulatory proteins like HSPGs or CDO. As mentioned  
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Figure A3. Shh-EGFP and ShhC25S-EGFP both signal in the 
chick neural tube.  (A & B) Chick embryos at approximately 
Hamburger-Hamilton (HH) stage 10 were electroporated into one 
side of the developing neural tube (NT) with either recombinant 
Shh-EGFP or ShhC25S-EGFP.  Embryos were collected at HH 
19 to 21, the NT was isolated, fixed, OCT embedded and frozen 
at -80 degrees C. 20µm sections were cut and processed for 
immunofluorescence analysis. Cells, electroporated with 
recombinant Shh are EGFP positive. (A) Shh overexpression, 
reduced Pax 7 (DSHB Pax7 1:500; goat anti-mouse Alexa 555) 
staining in the electroporated dorsal NT compared to the non-
electroporated control side. (B) Shh overexpression, increased 
the range of Isl1 expression (DSHB Isl1 1:1000; goat anti-mouse 
Alexa 555) staining in the electroporated ventral NT compared to 
the non-electroporated control side. (C) Chick embryos 
electroporated with pCIG-Shh-EGFP-IRES-dsRED.   
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Figure A4. Cellular distribution of Shh(n-5) is comparable to 
ShhC25A and Shh25S.  (A–C) Figure 12 with the addition of 
Shh(n-5). Shh(n-5) behaves in a similar fashion to ShhC25A and 
ShhC25S.  Distinct influences of the cholesterol and palmitate 
modifications on Shh cellular localization were revealed by 
quantification of mean fluorescence indices (MFI) for 5E1-Alexa 
647 staining of NIH3T3 fibroblasts co-transfected with 
recombinant Shh (0.06 ng to 1000 ng) and EGFP (1050 ng).  See 
figure 12 for more details. Following removal of the palmitate 
alone (Shh(n-5), ShhC25A & ShhC25S) surface expression was 
maintained (C) while internal expression levels were reduced to 
that of recombinant ligand lacking any lipid-modification (compare 
ShhC25A/S and Shh(n-5) to ShhNC25A in B).  (D) To quantify the 
amount of cell-associated Shh ligand that was expressed on the 
surface, the MFI for internal staining was subtracted from that for 
total cell staining.  Control cells were mock transfected, and MFI 
is shown relative to control.  Again the percentage of Shh(n-5) on 
the cell surface is comparable to ShhC25A and ShhC25S 
(compare Figure A4D and 12D).   
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Figure A5. Shh(n-5) signaling potency is significantly less than 
ShhC25A and ShhC25S, even though all lack the palmitoyl adduct.  (A) 
Each of the constructs conferred dose dependent and similar expression 
levels of recombinant Shh protein.  Shown are the sums of protein 
measurements in cell lysate and culture medium from NIH3T3 cells 
transfected with a range of cDNA for constructs in which Shh palmitoylation is 
abolished (ShhC25S, ShhC25A and Shh(n-5)).  (B & C) NIH3T3 fibroblasts 
were co-transfected with expression plasmids for recombinant Shh (Shh, 
ShhC25S, ShhN, or ShhNC25S), EGFP, Gli-reporter (8xGli-luciferase) and 
LacZ, changed to low-serum medium for 40 hours, and then analyzed for 
chemiluminescence.  (B) Shown is the relative luciferase value as a function 
of transfected recombinant Shh(n-5) cDNA. Shh(n-5) signaling was 
significantly reduced in comparison to ShhC25S and ShhC25A.  (C) Analysis 
of relative luciferase activity as a function of recombinant ligand expressed 
per transfected cell (pg/cell).  Though the cellular distribution of Shh(n-5) is 
comparable to ShhC25S and ShhC25A, its EC50 (0.090) is markedly higher.  
Thus, the significant reduction in signal potency is due to the amino terminal 
deletion and is attributed to more than just a loss of the palmitoyl adduct. 
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Figure A6. Cellular distribution of Shh(n-5) is comparable to other 
mutant recombinant Shh constructs lacking the palmitoyl adduct.  (A) 
As described (Figure 9B), precise quantification of recombinant Shh protein 
concentrations in either the cell lysate or culture medium revealed both 
cholesterol and palmitate modifications confer cellular association.  Shown 
are the averages of Shh protein measurements from cells transfected with 
cDNA (62.5 ng to 500 ng in two fold increments).  Shown here is Shh(n-5) 
and ShhN(n-5) which were omitted from figure 9B.  Shh(n-5) is not modified 
by palmitate and is lacking amino acid residues C25 to R29.  Shh protein, 
measured in lysates from cells expressing Shh(n-5) resulted in approximately 
68% of protein secreted.  This is comparable to results from ShhC25A and 
ShhC25S (Figure 9B).  Less than 5% of ShhN(n-5) protein is cell associated 
which is consistent with data from ShhNC25A and ShhNC25S; all three of 
these recombinant Shh proteins are not lipid modified. (B) Shown are 
integrated data from ELISA and flow cytometric measurements of 
recombinant form of Shh(n-5) expressed inside cells, on the cell surface, or 
secreted in the culture medium.  Protein distribution within the cell is 
comparable to ShhC25A and ShhC25S, that also lack a palmitoyl adduct 
(Figure 13). 
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Figure A7. DMEM-F12 medium enhances Gli-
reporter based Shh signaling assays. Light 2 
cells (a clonal NIH 3T3 cell line stably 
incorporating Gli-dependent firefly luciferase and 
constitutive Renilla luciferase reporters) were 
incubated for 38 hours with three different 
concentrations of ShhN conditioned medium (0.21, 
0.41, and 0.82 nM) in 0.5% calf serum in either 
high glucose DMEM, DMEM-F12, or adherent 
glioma neural stem cell medium (AGNSC). Shown 
are relative firefly luciferase values, normalized to 
Renilla luciferase, as a function of Shh protein 
(nM) added.  Using DMEM-F12 markedly 
enhances Shh signaling.   
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Figure A8. Shh conditioned medium from recombinant wild-type 
and mutant Shh bind to 5E1 conjugated beads with similar affinity.  
Conditioned medium was collected from HEK293T cells transfected with 
recombinant Shh constructs (Shh, ShhC25A, ShhC25S, ShhN, 
ShhNC25A, and ShhNC25S) and control (untransfected).  Shh 
conditioned medium was quantified via ELISA.  The same concentration 
of Shh protein and the same volume of conditioned medium (DMEM 
was added to supplement the volume where needed) was purified using 
a 5E1 Affi-Gel affinity matrix column.  Shown is the percent of Hh 
protein that bound to the column and what was recovered after passing 
the medium through the column. The unbound Shh protein was 
quantified by ELISA and subtracted from the input concentration to 
determine Each of the recombinant Shh constructs bound 5E1 with 
similar affinities.   
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earlier the five amino acid deletion may interfere with the ability of heparin (from 
HSPGs) to correctly associate with the C-W domain with in Shh.  
  
Figure A9: The role of Shh lipid adducts in Shh temporal expression 
 These data support the results from Shh signaling assays described in 
Chapter II Figure 17.  
 
Figure A10 - Fluorescence imaging studies 
 By live-cell imaging we have detected ShhA193-EGFP within transfected 
cells and also in neighboring cells. These studies were performed in another 
Shh-responsive cell line, C3H10T1/2 mouse embryonic fibroblasts (Pepinsky et 
al. 1998), that are larger than NIH3T3 cells and have more extensive membrane 
projections. Fluorescent protein subcellular localization markers in live cells and 
antibody staining in fixed cells may be used to characterize the cellular 
compartments in which the various Shh-fluorescent protein molecules are 
localized. ShhA193-ECFP was transfected (Fugene, Roche) into one plate of 
cells and Ptc-EYFP was transfected into another. On the following day, both 
cultures were harvested, washed with PBS and coplated on a poly-lysine coated 
coverslip and subsequently imaged at 37˚C in a live-cell imaging chamber 
(Bioptechs FCS2). By this method, extensive co-localization of ShhA193-ECFP 
and Ptc-EYFP can be observed in vesicular compartments. Because, the cells 
were transfected in separate culture plates, we believe that the ShhA193-ECFP 
was delivered from adjacent cells in the co-culture. To confirm this observation a  
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Figure A9. Role of Shh lipid adducts in osteoblast 
differentiation. NIH3T3 fibroblasts were transfected 
with equal amounts of expression plasmids for 
recombinant Shh (Shh, ShhC25A, ShhC25S, ShhN, 
ShhNC25A, or ShhNC25S), changed to low-serum 
medium at different time points (cell exposure to low 
serum medium is shown in the figure), lysed 
simultaneously at 120 hours, and then analyzed for 
alkaline phosphotase (AP) via fluorescence. Shown 
are relative AP levels as a function of induction time. 
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Figure A10. Images of Shh and Ptc fused to 
fluorescent proteins. (A & B) ShhA193-EGFP expression 
in C3H101/2 cells stained with an antibody against EGFP.  
Note that staining can also be detected in both transfected 
cells (asterisk in B) and neighboring cells (arrows in A and 
B).  Double labeling with actin is shown in A (red staining). 
(C&D) Live cell imaging of ShhA193-ECFP (pseudocolored 
red) and Ptc-YFP (pseudocolored green) in separately 
transfected and then coplated cells. Arrowheads indicate 
co-localization of Shh and Ptc. 
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Figure A11. ShhC25SA193-EGFP retains Shh 
signaling. ShhA193-EGFP and ShhC25SA193-
EGFP both retain the ability to signal and bind 
Ptc.  These constructs were used to generate 
zebrafish transgenic lines. Note: signaling cannot 
be compared as protein levels were not 
quantified and a less responsive NIH3T3 cell line 
was used.  See Chapter II for discussion on 
signaling capacity of Shh versus ShhC25S.   
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bicistronic vector that expresses both Ptc-EYFP and nuclear-localized dsRED 
fluorescent protein should be used. These findings are consistent with a second 
activity of Ptc to sequester Hh proteins through receptor-mediated endocytosis 
(Chen and Struhl 1996; Incardona et al. 2000). 
  
Shh lipid adducts and association with cytonemes 
 Additional studies described below are inspired by generation of Shh-FL 
proteins and preliminary results from Figure A10. Cytonemes, thin actin based 
filaments, that project from cells in a purposely oriented and specifically 
distributed manner are thought to be involved in morphogen trafficking and long 
range cellular communication (Reviewed in (Bryant 1999)). From in vitro 
experiments using wing disc fragments, cytonemes on imaginal wing discs are 
induced by tissue fragments containing the signaling center associated with the 
anterior-posterior boundary. Additionally, formation of cytonemes are dependent 
on attractive signals such as Hh and fibroblast growth factor (FGF). It appears 
that cytonemes are not limited to Drosophila and have been observed in cultured 
limb buds subjected to FGF and in chick embryo cells (Ramirez-Weber and 
Kornberg 1999; Roy et al. 2011). Viruses also use cytonemes and similar cellular 
projections to spread from cell to cell. Viral pathogens use these filopodial type 
bridges mediated by ligand receptors to transfer surface associated complexes 
and cytoplasmic content between cells (Reviewed in (Sherer and Mothes 2008)).  
Cytonemes are particularly interesting when considering a lipid modified 
morphogen and how it may be secreted and handled in the context of long range 
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signaling (Reviewed in (Teleman et al. 2001)). Intriguing is the possibility that 
distant cells may be in contact via cytonemes with Hh generating cells. If 
cytonemes, or other cellular extensions, are involved in Shh signaling, then they 
could transport Shh or a downstream signaling component. Graded activity of the 
Shh pathway could be accounted for by time- or transport-dependent decay of 
the intermediate as it cycles back to the cell body. Cytonemes are destroyed by 
fixatives like formaldehyde and methanol (Reviewed in (Bryant 1999)), and 
therefore live-imaging of Shh-FP molecules or electron microscopy are well 
suited for these types of studies.  
Preliminary results, by live-cell imaging and antibody staining, 
demonstrate detection of ShhA193-EGFP within transfected cells and also in 
neighboring, untransfected cells (Figure A10). These studies were performed in 
another Shh-responsive cell line, C3H10T1/2 mouse embryonic fibroblasts 
(Pepinsky et al. 1998), that are larger than NIH3T3 cells and have more 
extensive membrane projections. One interesting observation is that ShhA193-
EGFP can be detected in neighboring cells in structures that resemble focal 
adhesions (arrows in Figure A10 A and B). This observation may relate to the 
previously reported finding that C3H10T1/2 cells attach readily to ShhN coated 
plates, but not to plates coated with amino-terminal truncated ShhN, indicating 
that the amino-terminus may promote cell-extracellular matrix contact (Williams 
et al. 1999). Shh association and trafficking via cytonemes would be interesting 
to pursue further. Additionally, filopodia type structures are visible during 
zebrafish gastrulation (Besser et al. 2007). It would be fascinating to determine if 
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cytonemes are in fact present in zebrafish, if they serve a purpose in gradient 
formation or morphogen trafficking, and what role, if any, the Hh lipid adducts 
play.  
 
Figure A12: Shh protein is detectable in human cerebrospinal fluid 
In mice embryos, Shh was detected in the circulating embryonic 
cerebrospinal fluid (CSF) (Huang et al. 2010).  It is of interest to determine 
whether human adult CSF also contains Shh and whether the presence of 
absence correlates with diseases known to have a role for Shh. If, for example, 
patients with Shh responsive gliomas (Ehtesham et al. 2007), show elevated Shh 
levels, this could provide physicians with another diagnostic tool to determine a 
disease state. Current methods (ELISA) are only barely able to detected Shh 
protein levels within the CSF. Concentrating Shh protein by affinity 
chromatography using 5E1 anti-Shh antibody may help increase detection by 
ELISA.  
 
A2.2 – Alternative zebrafish experiments 
 
Alternate approaches to visualizing Shh-EGFP 
Our main concern is inadequate levels of zShh-EGFP expression, which 
will hinder use of live embryo imaging techniques. To compensate, we have 
described immunohistochemistry experiments that will use EGFP antibody 
detection instead. With this technique we still may not be able to visualize zShh- 
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Figure A12. Shh protein is detectable in human cerebrospinal fluid. 
We examined human CSF in three samples and control (purified Shh 
protein). Each sample was analyzed over several dilutions by ELISA 
(filled circle). To determine specificity of Shh signal, Shh protein was 
pre-incubated with excess 5E1 anti-Shh monoclonal antibody prior to 
ELISA (open circle). (A) As expected, in the control sample (purified Shh 
protein), Shh was detected and neutralized with the 5E1. (B) In sample 
4 (CSF from a patient with Multiple Sclerosis), Shh protein can be 
measured above background and is also diminished upon 5E1 
incubation. (C & D) Either no Shh protein is present or protein amounts 
are below the level of detection. Sample 5 is from a patient with optic 
neuritis and otherwise normal CSF.    
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EGFP in structures away from the source of signal. As an alternative, we will use 
Tyramide Signal Amplification system (Perkin Elmer) that uses the catalytic 
activity of horseradish peroxidase and fluorescent tyramide substrates to 
generate reactive tyramide species that covalently bind to the enzyme activity 
site in order to increase detection sensitivity. Shh is a diffusible ligand, therefore 
we may lose Shh protein while fixing the embryo during washing steps, thus a 
more stringent fixing method that uses ethanol, paraformaldehyde and acetic 
acid may be required. In addition, Tg[UAS-zShh-EGFP] and Tg[UAS-
zShhC24SEGFP] lines may have sufficient amounts of endogenous Shh present to 
compensate for any abnormality in hedgehog signaling, thus we may not be able 
to observe changes in markers of graded signaling. Therefore, generating these 
lines in syut4 (Schauerte et al. 1998; Park et al. 2004) background would be 
useful. 
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